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1CHAPTER I
INTRODUCTION
Cardiovascular disease is a major public health concern in the United States1 with an
estimated health care cost of over $300 billion annually due to disability and death 2, 3 .
According to the American Heart Association, cardiovascular disease mortality
accounted for up to 60% of all mortality1. According to CDC, heart disease and stroke
are the principal components of cardiovascular disease and account for up to 40% of all
deaths in the nation4. According to American Heart Association, the death rate due to
cardiovascular disease accounted for 37.3% of all deaths in 20031. It is estimated that
over 71,300,000 adults live with some form of cardiovascular disease in the nation and 1
in 3 adults has some form of cardiovascular disease1.
Cardiovascular disease is the leading cause of death in both genders among racial and
ethnic groups2. There is disproportion in death and disability due to cardiovascular
disease in minority and low income populations in the nation3. Among African
Americans 9.9% have heart disease, 5.3% have coronary heart disease, 31.6% have
hypertension and 3.5% have had a stroke5. Among American Indians 13.8% have heart
disease, 8.2 % have coronary heart disease, 23.9% have hypertension and 3.1% have had
a stroke5.
2It is estimated that nearly twice as many women die from heart disease compared to all
forms of cancer6. According to the AHA, cardiovascular disease caused death every
minute among women in 2003 in the United States1. Over 480,000 American women
live with some form of cardiovascular disease every year1. Heart disease is the leading
killer of minority women in the United States7. Among American Indians aged 18 years
or older, 61.4% of women have one or more risk factors such as high blood pressure,
current cigarette smoking, cholesterol, obesity and diabetes for heart disease8.
According to the U.S Department of Health and Human Services, African American
women had the highest age-adjusted death rate due to major cardiovascular disease and
stroke when compared to all American females in 1997-1999. The death rate was more
than 395.5 per 100,000 women9. High blood pressure and smoking rates are higher in
African American women than all groups of women. African American women of 20
years of age or older have higher blood pressure levels (36.4 and 36.0) than white non-
Hispanic women (19.7)10.
Oklahoma ranks third highest in the nation for the prevalence of cardiovascular
disease and claimed 317/100,000 lives in 199911. According to the state department of
health, cardiovascular disease is the leading cause of death in American Indian and
African American populations in Oklahoma in 200312. Heart disease accounted for up to
31% of Oklahoma’s deaths in 200113. Coronary heart disease accounted for 1 in 5 deaths
in women and was the leading cause of death among females in Oklahoma in 2003 3.
The likelihood of a woman in Oklahoma to die from heart disease is 50% more than
cancer14. Minority women from racial and ethnic groups face tremendous social,
economic, and cultural barriers to achieving optimal health15. Minority women face
3lower levels of education, higher levels of unemployment and lack public health
insurance. It is estimated that nearly 13 million women live in households with income
below the Federal poverty level16. Thus minority women have a high risk of death and
disability from heart disease, stroke, diabetes, and chronic obstructive pulmonary
disease15. Thus it is evident that minority women in rural Oklahoma also live below the
poverty line and is at higher risk for heart disease.
In Oklahoma, the prevalence of health disparities varies according to race and
ethnic minority groups. It was estimated that the annual age adjusted death rate due to
heart disease among African Americans accounted for up to 582 and the death rate
among American Indians accounted for up to 278 of all deaths between 1991-199517.
Obesity is associated with a spectrum of cardiovascular disorders18. One of the
ways by which adiposity could contribute to the development of cardiovascular disease is
through increased leptin production19-21. Leptin, the ob-gene product is a protein
hormone expressed in the adipose tissue22. Leptin correlates with body fat mass in obese
and lean subjects23, 24. Leptin levels are elevated in obese compared to lean subjects25.
Insulin is a key hormone involved in glucose metabolism and induces vasodilation.
Resistance to the utilization of insulin in obese subjects results in increased insulin
production to maintain normal rate of glucose uptake. Thus insulin resistance can
adversely affect the cardiovascular system26.
Waist circumference is a measure of abdominal obesity specifically visceral fat27.
Abdominal obesity is associated with increased cardiovascular disease in men and
women28. Risk factors of cardiovascular disease such as high blood pressure, increased
triglycerides, total cholesterol, HDL cholesterol and LDL cholesterol in abdominally
4obese women has been associated with a waist circumference greater than 88cms in
women27.
However, there is a lack of sufficient data regarding the prevalence of cardiovascular
disease in Oklahoma among ethnic minority groups.
Therefore, the following hypotheses were developed
1. There will be a difference between leptin levels, insulin resistance and waist
circumference in American Indian and African American women.
2. Blood leptin concentration will be positively correlated with cardiovascular risk
factors in American Indian and African American women.
3. Insulin resistance will be significantly correlated with cardiovascular risk factors in
American Indian and African American women.
4. Waist circumference is a predictor of cardiovascular risk in American Indian and
African American Women.
5. Waist circumference is positively correlated to insulin resistance in American
Indian and African American women.
Based on the hypotheses, the following objectives were developed
1. To determine if there is an ethnic difference between leptin levels, insulin
resistance and waist circumference in American Indian and African American Women
2. To determine the correlation of blood leptin concentration with cardiovascular risk
factors in American Indian and African American Women
3. To examine the relationship of insulin resistance to cardiovascular risk factors in
American Indian and African American Women
54. To investigate whether waist circumference is a predictor of cardiovascular risk in
American Indian and African American Women.
5. To determine the correlation of Waist circumference and Insulin resistance in both
ethnic groups
6CHAPTER II
REVIEW OF LITERATURE
CARDIOVASCULAR DISEASE
Global Prevalence Of Cardiovascular Disease
Cardiovascular disease is a cluster of disorders of the heart and blood vessels
which includes coronary heart disease, cereberovascular disease, hypertension, peripheral
vascular disease, heart failure, rheumatic heart disease, congenital heart disease and
cardiomyopathies 29. It is the most common cause of death worldwide in both men and
women. According to The World Health Report 2003 by the World Health Organization,
cardiovascular disease accounted for up to 16.7million deaths globally with 7.2 million
due to ischemic heart disease, 5.5 million due to cerebrovascular disease and 3.9 million
due to hypertension and other heart conditions. Cardiovascular disease deaths accounts
for one third of global deaths in low and middle-income countries30. In 1999
cardiovascular disease deaths in the low and middle-income countries accounted for
approximately 80% of global cardiovascular disease deaths30.
Cardiovascular disease will be the leading cause of death in developing countries
by 2010. In developed countries it is the leading cause of death31. According to World
Health Report on Violence and Health, 2002, the leading causes of death among the
WHO member states in 2000 were ischemic heart disease and cereberovascular disease.
7Ischemic heart disease accounted for up to 12.4% of total deaths and cereberovascular
disease accounted for up to 9.2% of all deaths. Cardiovascular disease risk poses a global
threat in developing countries and industrialized nations.
Prevalence Of Cardiovascular Disease In United States
Cardiovascular diseases are the leading cause of death among men and women of
all racial and ethnic groups in the country32. According to CDC, it is estimated that
almost 70.1 million Americans live with some form of cardiovascular disease33. The
principal causes of cardiovascular disease death among men and women in the United
States are coronary heart disease and stroke34. According to the CDC, heart disease and
stroke are the principal components of cardiovascular disease and accounts for up to 40%
of all deaths in the nation4.
Health Disparities Among Minority Populations
Health disparities among minority populations can be categorized by race,
ethnicity and socioeconomic status in the United States35. Racial and ethnic minority
groups are growing rapidly in increasing proportions in the United States. According to
the US Census Bureau 2000, 1 of every 4 U.S residents belongs to a racial and ethnic
minority group36. It is estimated that, in 2010 the number of racial and ethnic minorities
will be 1 out of 3 U.S. residents. By 2050, the proportion will continue to increase and
minority population will account for 50% of the total U.S population37.
According to the 2004, National Healthcare Quality Report and National
Healthcare Disparities Report, women experience socioeconomic disparities in addition
8to gender and racial/ethnic disparities. It is estimated that over 53 percent of all African
American women receive poorer quality care than whites 38. They have access to worse
care by 29%. Minority women face lower levels of education, higher levels of
unemployment and lack public health insurance15, 39. It is estimated that nearly 13
million women live in households with income below the Federal poverty level16.
According to the CDC.1993-2004 report, it is estimated that the prevalence of
cardiovascular disease among non-Hispanic white men and women is 66%.
Cardiovascular disease rate among non-Hispanic black men and women is 85.8% 40 and
58.5% in Mexican American men and women.
According to the 2000 US Census Bureau report, African Americans accounted
for up to 12.9% of total population. Cardiovascular disease is the leading killer of
African Americans in the United States. According to the CDC, cardiovascular disease
deaths among African Americans accounts for up to 36.4% of all the other causes of
deaths every year. In 2001, the death rates among African Americans due to heart
disease were 30% higher than among whites. The death rates due to stroke in African
Americans were 41% higher than among whites34. Of all the minority groups, African
Americans tend to develop high blood pressure at a younger age10, 41. They are also less
likely to engage in physical activity 42.
According to the 2000 US Census Bureau, American Indians accounted for up to
1.5% of the overall population with a total of 4.1 million. Heart disease is the leading
cause of death among American Indians and Alaska Natives. In a study conducted in
Montana from 1991-1995 and 1996-2000 to calculate the heart disease and stroke
9mortality rate of American Indians and Caucasians, it was shown that the death rates due
to heart disease and stroke were higher in American Indian men and women compared to
white men and women thus suggesting that American Indians are at a higher risk of
developing cardiovascular disease compared to whites43.
According to National Vital Statistics, in 2002, the death rate among African
Americans due to cardiovascular disease accounted for up to 33.3% and death rate due to
cardiovascular disease among American Indians accounted for up to 24.5% of all deaths.
The prevalence of diabetes mellitus, a risk factor for heart disease was higher in
American Indians which accounted for up to 6% followed by African Americans which
accounted up to 4.4%44 (National Vital Statistics Reports, Vol 53, No 17, March 7, 2005).
Smoking increases the risk of cardiovascular disease. According to CDC, it is estimated
that in Oklahoma, the smoking rate among racial/ethnic groups in adolescents range from
13% among African Americans to 26% among American Indians45.
Ethnicity And Obesity
Obesity and overweight, a risk factor for cardiovascular disease in the U.S
population is at a higher rate among racial/ethnic minority populations such as African
Americans and American Indians compared with whites. The prevalence of obesity is
high among African Americans, particularly African American women. According to
CDC, between 1994 and 2000, obesity among African American men increased from
21.3% of American adults to 28.8% American adults. Between 1994 and 2000, obesity
among African American women increased from 39.1% of American adults to 50.8% of
American adults46. When compared to non-Hispanic white women, 69% of AA women
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are overweight or obese47. Data obtained from National Health and Nutrition
Examination Survey (NHANES) have shown that the prevalence of obesity is twice when
compared to European American women48.
American Indians suffer from obesity and overweight at younger ages. This is
due to an excess accumulation of fat in childhood among American Indians49. According
to CDC, in 1999 the prevalence of overweight among children and adolescents between
ages 5 to 17 was 39 percent of males and 38 percent females49, 50. The 1990 American
Indian School children Height and Weight Survey, conducted by the Indian Health
Service, showed that 40% of 5-18 year old American Indians were overweight51. Data
from other studies have observed that 22% of children were at risk for overweight
among American Indians between 5- 18 years of age, while 41% of the sample were
overweight52. The increasing prevalence of obesity and overweight among younger
people poses a health challenge for American Indian communities which increased the
risk of cardiovascular disease in this population.
Cardiovascular Disease And Women
Cardiovascular disease particularly coronary heart disease and stroke is the
leading killer of women in the United States53-55. Cardiovascular disease causes about
half a million deaths among women every year56. According to the CDC, it is estimated
that in 2002, 696,947 Americans died due to heart disease and this accounted for up to
51% of women57.
Minority women experience a number of health problems with shorter life
expectancy, higher incidence of chronic diseases and higher maternal and infant
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mortality. Increased poverty rate, lack of education and limited medical care have an
additional effect on overall health status of minority women58.
The cardiovascular disease is linked with a number of risk factors in minority
women. Cardiovascular disease is influenced by behavioral, social, cultural and
economic factors. Elevated blood pressure, cigarette smoking, hypercholesterolemia,
excess body weight, sedentary lifestyle and diabetes increase the likelihood of developing
the disease59.
Cardiovascular Disease In Oklahoma
The prevalence of death due to CVD in Oklahoma is the second highest in the
nation with 391.6 deaths per 100,000 populations11. According to officials at the
Oklahoma State Department of Health (OSDH) each day 30 Oklahomans die of heart
disease60. Coronary heart disease accounts for one in five deaths in women and was also
the leading cause of death among females in Oklahoma in 200360. The age-adjusted
mortality rates for diseases of the heart and stroke are higher in Oklahoma compared to
U.S 60. Heart disease accounted for approximately 32% of the state’s deaths in 200261.
An overall, cardiovascular disease claims 14,500 lives in Oklahomans. This accounts for
44% of all deaths in Oklahoma62. The associated risk factors for cardiovascular disease
in Oklahoma were higher than those in United States overall in many areas62.
Diseases of the heart were the leading rankable causes of deaths in Oklahoma
among African Americans and American Indians in 2003. This accounted for up to 3,205
deaths in Oklahoma and 2012 deaths per 100,000 which is more than the death caused by
malignant neoplasm and cereberovascular diseases63.
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In 1999, heart disease claimed 5,869 lives of women of Oklahoma. The
likelihood of women in Oklahoma to die from heart disease is 50% more than cancer14.
Smoking contributes to 25% of heart disease deaths among women in Oklahoma.
Obesity accounts for 32% of heart disease deaths. And sedentary lifestyle accounts for
35% of deaths annually. High blood pressure contributes to 29% of heart disease deaths
among Oklahoma women14. The use of oral contraceptives has also been found to
increase a woman’s risk of developing heart disease. In 2000,6% of Oklahoma adult
women had diabetes and these women have a two times greater risk of coronary heart
disease14.
CARDIOVASCULAR RISK FACTORS
Risk factors that increase the likelihood of developing cardiovascular disease are
high blood pressure, high blood cholesterol, Type2 diabetes, overweight and obesity30.
According to CDC, it is estimated that 65 million Americans aged 20 or older have high
blood pressure. It is also estimated that 107 million Americans aged 20 or older have
elevated blood cholesterol64. It is estimated that 30% of American adults are obese which
accounts up to 60 million34. According to NIH Statistics, it is estimated that 20.6 million
Americans aged 20 or older have diabetes65.
Framingham Risk Score
The Framingham Risk Score, developed by the National Cholesterol Education
Program Adult Treatment Panel (III) procedures, is a multivariate statistical model that
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uses age, sex, high density lipoproteins cholesterol, total cholesterol, systolic blood
pressure, and smoking. It predicts a person’s risk of having coronary heart disease over a
period of 10 years. The risk score calculator includes points for each risk factor. The 10-
yr risk for coronary heart disease is high if the points are equal or greater than 3066.
Systolic Blood Pressure
Epidemiologic studies have demonstrated the relationship between SBP and
cardiovascular risk. The Framingham Study was a 14 yr biennial follow up study of
5,127 men and women. Systolic and diastolic blood pressure data was compared to the
risk of developing coronary heart disease in this cohort of men and women. There was a
strong association of SBP with coronary heart disease risk compared to diastolic blood
pressure67. Another study conducted in the Framingham Heart Study participants
concluded that SBP was a strong predictor of congestive heart failure when compared to
diastolic blood pressure68.
The Brisighella Heart Study, a population based European study examined SBP,
diastolic blood pressure, pulse pressure and its relationship to coronary heart disease.
The study included men and women between the ages of 14-84. There was a 44%
increased risk at SBP of 120-139 mm Hg, 76% increased risk at SBP readings of 140-159
mm Hg and 109% increased risk at SBP greater or equal to 160mm Hg. The risk
increased with increasing levels of SBP but not diastolic blood pressure69.
In a 15 yr cohort study, two independent cross-sectional random samples were
investigated for subjects who participated in baseline surveys in 1972 and 1977. Men
and women aged 25-64 free of myocardial infarction were studied. Isolated systolic
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hypertension was defined as SBP >=160 mm Hg. The incidence of heart disease
increased with an increase in SBP. In women, isolated systolic hypertension was
significantly higher and increased the risk of myocardial infarction70.
He et al.71 conducted a meta-analysis of prospective cohort studies, epidemiologic
studies and randomized controlled trials to determine the association between SBP and
risk of coronary heart disease and stroke. SBP was more strongly associated with
coronary heart disease than diastolic blood pressure. A reduction of 12-13 mm Hg in
SBP readings was associated with 21% reduction in coronary heart disease, 37%
reduction in stroke and 25% reduction in total cardiovascular mortality71, 72.
In the Copenhagen City Heart Study, men and women were examined to estimate
the influence of blood pressure on the risk of stroke incidence. Again, SBP was more
strongly associated with stroke risk than diastolic blood pressure. SBP was the best single
predictor of cardiovascular events in this study73.
Total Cholesterol, HDL-Cholesterol, Diabetes
Epidemiologic studies indicate that high levels of serum total cholesterol are
related to coronary heart disease. The report on diet and health by the National Research
Council-National Academy of Sciences cited these studies in showing a stronger link
between total cholesterol and coronary heart disease74. The most prominent studies
include The Framingham Heart Study, Multiple Risk Factor Intervention Trial, Brown
and Goldstein’s research on low-density lipoprotein (LDL) receptors, Coronary Primary
Prevention Trial and The Helsinki Heart Study.
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The Framingham Heart Study investigated men and women for total cholesterol
and coronary heart disease risk over a period of 14 years. The total serum cholesterol
levels were between 150 and 300 mg/dl. A positive correlation between total serum
cholesterol and coronary heart disease rates was found. There was an increase in
coronary heart disease rate with an increase in total serum cholesterol75.
The Mulitiple Risk Factor Intervention Trial (MRFIT) was a randomized trial on
high risk middle aged men. The effects of coronary disease risk factors were tested in
this cohort. There was a strong association between total serum cholesterol and coronary
heart disease deaths over 6 years. The mortality rate was high for individuals with serum
cholesterol levels as low as 180mg/dl76. A reduction in serum total cholesterol by 1%
decreased the risk of coronary heart disease by 2%. The Helsinki Heart Study reported
that patients treated with drugs to lower the levels of total cholesterol also reduced the
incidence of heart disease77, 78.
A population based Italian study was conducted with a 10-yr follow up from
1983-2002. Men and women were examined and followed for elevated blood pressure,
smoking, diabetes, and total cholesterol/HDL ratio and the incidence of stroke. The risk
factors were independently related to incidence of stroke risk. It was shown that 80% of
the population was at a high risk of stroke incidence with elevated levels of all the risk
factors. In participants with only one unfavorable (not high) risk factor, the stroke rate
incidence was 76% lower than high risk participants with more than one risk factor79.
These results are consistent with earlier findings which examined the relationship of
lipids and risk of ischemic heart disease in middle-aged women80-82 which found that
16
there was an increased risk of myocardial infarction and coronary heart disease associated
with obesity, elevated blood lipids and apo lipoproteins.
In an 8-yr follow up of the MONICA Augsburg cohort study from 1984-1992,
men and women were examined and followed for hypertension, total cholesterol/HDL
ratio and smoking. Men had a higher systolic (137 vs.135 mm Hg) when compared to
women. Smoking more than 20 cigarettes per day increased the risk of myocardial
infarction by 70-80 %. The total cholesterol/ HDL cholesterol ratio greater or equal to
5.5 was a risk factor for myocardial infarction. These risk factors contributed to 65% risk
for non-fatal and fatal myocardial infarction in this Augsburg population83.
HDL-Cholesterol is an independent and inverse predictor of coronary heart
disease as well. In the Framingham study, men and women were evaluated for lipids and
lipoprotein values between 1969-1971. The major lipid risk factor was HDL- C in those
subjects who developed coronary heart disease after a period of time. There was an
inverse association of HDL-C with coronary heart disease84. Further analysis of the
Framingham data85 to investigate the incidence of coronary heart disease and lipoprotein
cholesterol levels found that at the 12-year follow up study, 50% of the participants with
higher HDL-C were at lower risk of coronary heart disease than those with lower HDL-
C. In the 12-yr follow up of the Prospective Cardiovascular Munster (PROCAM) study,
men and women of mean age 15-64 years were evaluated for the incidence of coronary
heart disease and its relationship with HDL-C levels. Individuals with HDL-C levels
<35mg/dL had a 4-fold increased risk of coronary heart disease within 6 years when
compared with levels >35mg/dL86.
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In the 10 yr follow up of the Atherosclerosis Risk Communities (ARIC) Study,
men and women free of coronary heart disease were investigated. A strong association of
increased coronary heart disease risk and total cholesterol, LDL-C, and triglycerides was
shown. There was a decreased risk of coronary heart disease in participants with elevated
HDL-C levels. High levels of lipoproteins were also associated with relative risks for
heart disease in both sexes87.
Evidence from the Coronary Primary Prevention Trial (CPPT) and Multiple Risk
Factor Intervention Trial (MRFIT) showed that a 1-mg/dl increase in HDL-C was
associated with a decrease in cardiovascular risk by 3% in women and 2% in men.
Hence an inverse relation of HDL-C and coronary heart disease was observed in these
studies.
Obesity
Obesity is a major risk factor for cardiovascular disease88. Measurement of body
mass index (BMI) has been used to define the population as normal weight (18.5 – 24.9
Kg/m2), overweight (25.0-29.9Kg/m2) and obese (30 Kg/m2)89. Obesity is associated
with accelerated coronary atherosclerosis in young adults. In the Pathobiological
Determinants of Atherosclerosis Youth Study (PDAY), BMI in obese young men aged
15-34 years was significantly correlated with increased fatty streaks and raised lesions in
the right coronary artery. The effect of BMI on the right coronary artery was higher in
men with thicker subcutaneous abdominal fat. It was also observed that the direct effects
of obesity such as HDL-cholesterol concentrations, smoking levels, hypertension, and
18
glycohemoglobin concentrations were significantly higher in this group and they
accounted for up to 15% of the effect of obesity in coronary atherosclerosis90.
The Healthy Women Study, conducted in a sample of premenopausal women
from 1983-1985, assessed the relationship between BMI, insulin and cardiovascular risk
factors such as blood pressure, triglycerides and HDL-C and fasting glucose. A
significant correlation of BMI and blood levels of insulin with all the risk factors except
cholesterol and apolipoproteins A-I and apolipoproteins A-II was observed. The
interaction between insulin and BMI was not significant. Thus it was suggested that at a
given level of insulin, an increase in BMI may be associated with elevated SBP and
triglycerides and apolipoprotein-B91.
McLaughlin et al.92 conducted a study in a cohort of normal, overweight, and
obese individuals to determine the relationship of body fat and cardiovascular disease
risk. Adiposity (BMI) and cardiovascular risk factors such as blood pressure, plasma
glucose, fasting plasma lipid, lipoprotein concentrations and fasting insulin levels were
measured. Elevated BMI contributed to higher low-density lipoprotein concentrations.
Insulin resistance, which may not be obvious in people with elevated BMI, contributes to
the development of cardiovascular disease.
Another study found that adiposity as measured by waist hip ratio (WHR) is a
predictor of coronary heart disease. Waist circumference which is a measure of
abdominal obesity is a marker of coronary heart disease in women. Women with a
WHRof 0.76 in were twice more likely to develop coronary heat disease and women with
a WHR greater than 0.88 were 3 times more likely to develop coronary heart disease.
Waist circumference and WHP were independently associated with coronary heart
19
disease after controlling BMI. This suggests that abdominal obesity is a major risk for
heart disease18.
LEPTIN
Leptin is an important regulator of food intake and energy expenditure. It is a
protein hormone produced by the adipocytes which was identified in December 1994 by
Friedman and co workers. It was first isolated in mice models with the sequencing of the
obese gene22. The mouse ob gene now called the leptin gene derived its name from the
Greek word leptos meaning thin. Leptin is a 16KDa protein product encoded from a 4.4
kilo base mRNA22 and is synthesized in white and brown adipose tissue93-95. Leptin
plays an important role in the regulation of food intake and energy expenditure96-98.
When recombinant leptin is administered to lean mice, it results in a substantial loss of
body weight and fat, reduced food intake and increased energy expenditure97, 99.
Martin et al.,100 observed a positive correlation of leptin levels with the energy
expenditure when the percentage body fat was controlled in cohort of normal weight
women. Leptin levels were associated with percent body fat, fat mass and body mass
index101.
Mechanism Of Action
The action of leptin takes place in the hypothalamus in the central nervous
system102, 103 where leptin binds to its receptors inhibiting food intake and decrease body
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weight. It has been identified that there are three distinct steps by which the leptin acts as
a regulator of food intake. First, leptin is produced by the adipose cells in to the blood
stream and it monitors the levels of energy stores in the body. Secondly, leptin signals
the adipose stores to the hypothalamus through leptin receptors. Finally, the sympathetic
nervous system controls the intake of energy and energy expenditure and maintains a
balance in energy. This feedback to the hypothalamus plays an important role in
maintaining body weight104, 105.
Leptin receptors (OB-R) mRNA are expressed in the hypothalamus and in other
tissues such as kidneys, lungs, liver, heart, small intestine, pancreas, adipose tissue,
spleen, testes, and ovaries106. Leptin receptor gene expression has been found to be an
important regulator of leptin in the hypothalamus. The expression of receptor mRNA
was higher in ob mice which do not produce leptin when compared to lean mice. The
administration of recombinant murine leptin in ob type mice decreases the intake of food
associated with reduced levels of receptor mRNA in arcuate region of the
hypothalamus105. This suggested that brain acts as an important site for the action of
leptin.
Decreased circulating soluble leptin receptor levels have been associated with
obesity in humans. Ogier et al.107 observed that obesity in humans is associated with a
decrease in circulating soluble leptin receptor levels. This study was conducted in obese
and lean men and women to determine the soluble leptin receptor levels, it was observed
that the soluble leptin receptor levels were lower in obese and overweight individuals
when compared to lean subjects. An inverse correlation of soluble leptin receptor levels
with percent body fat and leptin was observed. The ratio of circulating leptin to soluble
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leptin receptor levels correlated strongly with percent body fat. After a 3-month low
calorie diet, soluble leptin receptor levels in obese subjects increased with a decrease in
body fat. The leptin levels were higher in women when compared to men and strongly
correlated with body fat. Thus, this study suggested that soluble leptin receptor levels
increase when there is a decrease in fat mass and weight loss in lean subjects.
Leptin And Obesity
Human obesity is characterized by an increase in serum leptin concentrations
associated with an increase in leptin mRNA concentration in adipose tissue as well as an
increase in total body fat. Serum leptin concentrations and leptin mRNA content of
adipocytes are twice as high in obese subjects as in normal subjects. Serum leptin
concentrations are positively correlated with percent body fat25. A number of studies23, 24
conducted in humans has shown that the amount of body fat is the principal determinant
of the circulating levels of leptin in humans.
Leptin And Body Fat Distribution
In human obesity, serum leptin concentrations are correlated to subcutaneous
adiposity24, 108 but not to intra-abdominal fat109, 110. Subcutaneous fat may be the major
contributor of increased leptin concentration. Minocci et al.,24 determined that
subcutaneous fat and preperitoneal visceral fat was assessed. They found that the
subcutaneous fat thickness, abdominal fat index and the waist hip ratio correlated
independently with the serum leptin concentrations and were higher in women than men.
There was no significant relationship between the preperitoneal visceral fat and leptin
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concentrations. These results are in agreement with those reported by Vanessa and
colleagues111 in an earlier study. In a group of obese and non obese women, the secretion
rate of leptin from subcutaneous tissue was two or three times higher than visceral
adipose tissue.
In human studies, serum leptin concentrations have been reported to correlate
with the percentage of body fat 25, 112. A study conducted in normal and obese men and
women assessed the percentage of body fat by bioelectric impedance analysis. This
showed that elevated serum leptin concentrations were associated with an increase of
percent body fat in obese individuals. Decreased serum leptin was also observed due to
reduction in body weight. This study also found that the amount of ob mRNA in
adipocytes was higher in obese subjects when compared to normal subjects.
Leptin And Systolic Blood Pressure
In rats, high doses of leptin have been shown to increase mean arterial pressure
and hypertension 113, 114. It was suggested that a possible mechanism that may be
involved in elevated arterial pressure may be due to the activation of central nervous
system. These results are in agreement with a later study conducted by Marcelo and his
colleagues 115 who showed a positive correlation of leptin with arterial pressure. But the
effect of leptin administration on blood pressure has not yet been studied in humans.
Guagnano et al.116 have shown the association of serum leptin levels with casual
blood pressure and 24-hour ambulatory blood pressure in obese Italian women. In a
cohort of 40 women with android type obesity and 30 women with gynoid type obesity,
ambulatory blood pressure was monitored for 24 hours with an interval of 15 minutes
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during the day and 30 minutes during the night and compared with 20 nonobese healthy
women. Casual blood pressure was measured 3 times at 5 minute intervals in the
morning. Waist hip ratio (WHR) was used to differentiate between android (abdominal)
and gynoid (peripheral) fat distribution. The WHR greater or equal to 0.86 was defined
as android obesity and a WHR lesser or equal to 0.86 was defined as gynoid obesity117. It
was found that the serum leptin levels were significantly higher in women with android
obesity than women with gynoid obesity. There was a strong positive correlation
between leptin levels and 24-hr ambulatory blood pressure in women with android
obesity.
Schutte et al.118 conducted a study in a cohort of hypertensive obese/overweight
African and normotensive obese/overweight women. The effect of leptin on blood
pressure and arterial compliance was investigated. Arterial compliance was measured by
stroke volume over pulse pressure. Stroke volume is the volume of blood ejected from
the ventricle with each beat of the heart. Pulse pressure is the change in blood pressure
during the contraction of the heart. It was observed that leptin levels were higher in
obese/overweight hypertensive and normotensive women when compared to lean women
but similar in the normotensive and hypertensive obese overweight groups. It was
observed that leptin positively correlated with SBP and pulse pressure only in the
obese/overweight hypertensive group. Leptin levels also correlated negatively with
arterial compliance thus suggesting a positive role of leptin in the development of
cardiovascular disease.
Suter et al.119 conducted a study in a group of overweight subjects with
hypertension and healthy non-hypertensive subjects. The effect of plasma leptin levels
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on blood pressure and heart rate in these subjects was investigated. There was a
significant correlation of plasma leptin levels with systolic blood pressure in all women,
after adjusting for body weight. Heart rate correlated significantly with leptin levels in
all subjects. It was suggested that the relationships were statistically not very strong and
may be due to the heterogeneity of study population.
Cardiovascular Disease And Leptin
Leptin is a novel, independent risk factor for the progression of disease of the
heart120. Soderberg et al.19 observed that higher leptin levels, total cholesterol and Apo-I
predicted acute myocardial infarction in a cohort of obese Swedish men. High leptin
levels were positively associated with high BMI, high blood pressure and high insulin
levels. In the 5 yr follow up West of Scotland Coronary Prevention Study, leptin levels
were examined in subjects who experienced coronary events and compared with controls.
It was observed that with an increase in leptin levels, the relative risk of a future coronary
event increased20.
Ciconne et al.21 showed that the concentration of human plasma leptin is
independently associated with the intima-media thickness of the common carotid artery.
This was studied in a cross-sectional sample of obese men and women aged 18-45 years
of age. Intima media thickness of the common carotid artery was quantified by high
resolution B-mode ultrasound imaging was positively correlated with leptin, age, BMI
and waist circumference and negatively correlated with insulin sensitivity in men and
women.
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A cross-sectional study was conducted in a cohort of men and women with type-2
diabetes to determine the levels of plasma leptin and its association with coronary
atherosclerosis. Coronary artery calcification (CAC), which is a measure of
atherosclerosis, was measured in these subjects using ultra fast computed tomography.
Plasma leptin levels were significantly associated with coronary artery calcification after
controlling age,gender,BMI and CRP levels suggesting a positive role of plasma leptin
levels in the progression of cardiovascular events121. In The Atherosclerosis Risk in
Communities (ARIC) study122, the incidence of coronary heart disease was higher at
higher carotid intima media thickness. Thus, it is possible that leptin through its effects
on calcification and carotid intima media thickness, is a predictor of coronary heart
disease incidence.
Schulze et al.123 conducted a study in a group of 53 patients with chronic heart
failure. Serum leptin concentrations and serum concentration of soluble leptin receptor
was measured in these subjects. It was shown that the leptin concentrations and
concentrations of leptin receptor were higher in patients with congestive heart failure
when compared with the healthy controls. It was also found that there is a strong positive
correlation of serum leptin and TNF- in patients with severe exercise intolerance. This
study suggests that increased concentrations of leptin and soluble leptin receptor in
patients with congestive heart failure may be due to increased levels of proinflammatory
cytokines.
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Interrelationship Of Inflammation, Cardiovascular Disease And Leptin
Inflammation is involved in the etiology of cardiovascular diseases particularly
atherosclerosis, ischemic heart disease and heart failure124-126. C-reactive protein, a
marker of inflammation and an important indicator of cardiovascular risk127-131 is
associated with a sequence of cardiovascular events in patients with acute coronary artery
disease, angina pectoris and myocardial infarction in healthy men and women. Increased
levels of leptin are associated with increased CRP132. In a random sample of Finnish men
and women, associations of CRP, IL-6 and TNF  factor with coronary heart disease
incidence events and cardiovascular disease events were analyzed. The cohort was
followed up for a period of 10 years. Increased CRP levels and TNF  factor were
significantly associated with the risk factors for the incidence of coronary heart disease
and cardiovascular disease such as total cholesterol, hypertension and triglycerides in
men when compared to women133.
Inflammation And Atherosclerosis
Atherosclerosis is an inflammatory disease134. Coronary atherosclerosis is a
disease of the coronary arteries characterized by a combination of changes in the intima
of arteries. Fatty granulomatous lesions develop in the arterial wall and lead to the
hardening of vessels. The lesions, known as atheroma derived its name from the Greek
word meaning “gruel”, are characterized by thickening of the intimal wall, deposition of
lipid, deformation and fragmentation of the internal elastic membrane. In advanced
cases, it results in fibrosis and calcification. Atheromas have 2 major constituents
namely, fat and fibrous tissue which gives rise fatty plaques and pearly plaques. As a
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result of the formation of atheroma, it can erode the wall of the artery and diminish the
elasticity of the artery. Thus thrombosis or blockage of the arteries takes place. Hence,
the symptoms and signs of ischemic heart disease occurs135. According to the National
Cholesterol Education Program, increased low density lipoprotein (LDL) results in the
storage of lipids which are involved in an ongoing inflammatory response136.
Ross et al.137 proposed that endothelial dysfunction leads to atherosclerotic
lesions. The possible causes of this dysfunction are due to hypertension, cigarette
smoking, elevated LDL levels and diabetes mellitus. Endothelial dysfunction results in
the alteration of the homeostatic properties of endothelium. At the point of injury, when
the inflammatory response does not remove the offending agents effectively, then these
responses stimulates the proliferation of the smooth muscle cells that becomes intermixed
at the area of inflammation and forms an intermediate lesion. When these responses
continue, the formation of lesions leads to further enlargement that thickens the artery
wall. The artery wall prevents the thickening by the process of dilation, so that up to a
point the lumen remains unaltered. During worse conditions, the lesion may then intrude
in to the lumen and alter the flow of blood when the artery wall can no longer dilate.
Van Dielen et al.138 in a cohort of morbidly obese individuals examined the
association of obesity, leptin and the development of an inflammatory state.
Inflammatory markers such as soluble TNF- receptors, acute phase proteins, and lip
polysaccharide binding protein, serum amyloid, CRP, and plasminogen activator
inhibitor-1 (PAI-1) were measured. Leptin concentrations significantly correlated with
BMI in these subjects. It was observed that there was a significant correlation of leptin
with TNF  receptors such as TNFr55 and TNFr75. Thus it was concluded that in obese
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subjects, an increase in leptin concentrations was associated with the increase in
inflammatory markers suggesting a positive role of leptin in the regulation of
inflammation139, 140.
INSULIN RESISTANCE
Insulin Resistance And Body Fat
Insulin resistance is a condition in which the peripheral target tissues are unable to
respond properly to normal circulating concentrations of insulin leading to hypersecretion
of insulin by the pancreas141. The process by which insulin action takes place is by
binding to insulin receptors on target cells. This results in the uptake of glucose through
the glucose transport mechanism and its subsequent metabolism in insulin sensitive
tissues142, 143. So in insulin resistant condition, there is a substantial increase of insulin
production in the attempt to maintain a normal rate of glucose uptake.
Abdominal body fat is closely associated with insulin resistance. Carey et al.144
conducted a study in normal and obese women to determine the relationship of insulin
resistance and abdominal obesity in these groups. Obese women with abdominal
subcutaneous fat as opposed to peripheral non-abdominal fat showed a stronger
relationship with insulin sensitivity. These results were consistent with other cross
sectional studies conducted in humans that demonstrated a positive correlation of insulin
resistance with abdominal adiposity. Researchers observed the association between race,
sex, abdominal obesity, hyperlipidemia and fasting insulin levels in black males and
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white males with hypertension. The fasting insulin levels were higher in black males
when compared to white males. Abdominal obesity and hyperlipidemia significantly
correlated with fasting insulin levels in black males when compared to white males.
Abdominal obesity was also associated with insulin sensitivity in black males. Hence it
was suggested that abdominal obesity or hyperlipidemia doubled the risk of
hyperinsulinemia145. But the mechanisms of insulin resistance in obesity are not fully
understood.
Abdominal fat can accumulate either viscerally or subcutaneously. Many
investigators146-149 have found that excess accumulation of subcutaneous fat is more
strongly associated with insulin resistance than visceral fat. Kelley et al.147 partitioned
abdominal subcutaneous adipose tissue in to depots of fat namely, superficial
subcutaneous adipose tissue (posterior half of the abdominal wall) and deep subcutaneous
adipose tissue (anterior half of the abdominal wall). A cross sectional abdominal
computed tomography was performed in a cohort of lean and obese men and women.
There was a strong positive correlation between insulin resistance and deep subcutaneous
adipose tissue. Insulin resistance was also strongly related to visceral adipose tissue.
Similarly, researchers found that central abdominal fat in obese early postmenopausal
women is a strong correlate of insulin resistance. Intraabdominal fat and subcutaneous
fat was inversely and independently related to insulin sensitivity after adjusting for total
fat150.
The accumulation of visceral fat contributes to insulin resistance. Ross et al.151
investigated the relationship of insulin resistance between visceral and total abdominal
adipose tissue and muscle composition in a cohort of 40 abdominally obese
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premenopausal women. Abdominal fat, which includes visceral and subcutaneous
adipose tissue, was measured using magnetic resonance imaging. Insulin mediated
glucose disposal rate was measured by hyperinsulinemic euglycemic clamp. It was
observed that abdominally obese subjects had higher visceral adiposity when compared
to abdominal adiposity. There was also a strong association of glucose disposal rate to
visceral adipose tissue when compared to abdominal adipose tissue. Additionally, the
association of visceral adipose, subcutaneous adipose tissue, total fat mass, physical
activity expenditure, and peak VO2 with glucose uptake in obese postmenopausal women
was examined. Visceral adipose tissue was inversely related to glucose uptake with
higher visceral adipose tissue levels at lower glucose disposal per Kg lean body mass152.
Upper body fat is associated with insulin resistance due to its relationship with
non-esterified fatty acids from adipose tissue. Several studies suggest that upper body
obesity is associated with increased free fatty acids release153-156. In a study of upper
body obese women, lower body obese women and non obese women. It was shown that
insulin resistance was associated more with upper body fat than lower body fat. The
difference in body fat distribution was associated with abnormalities in the release of free
fatty acids metabolism. Palmitate turnover, which is a measure of lipolysis in adipose
tissue, was observed to be higher in upper body obese women than lower body obese
women156. A decline in glucose uptake is associated with an increase in free fatty acid
concentration. Decreased glycogen synthesis and carbohydrate oxidation was also
observed with reduced glucose uptake. The possible mechanism for decreased glucose
uptake is suggested to be due to lowered glucose transport or phosphorlyation in subjects
with increased free fatty acids157.
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Roden et al.158 observed plasma concentrations of free fatty acids, increased by an
infusion of a triglyceride emulsion combined with heparin to activate lipoprotein lipase
using carbon-13 and phosphorus NMR spectroscopy techniques in 9 healthy subjects. A
decreased rate of muscle glycogen synthesis by 50% and a decreased rate of glucose
uptake by the whole body by 46% of control values were observed. Elevated plasma free
fatty acids inhibited glucose uptake with a reduction in glucose oxidation rate and muscle
glycogen synthesis. This suggested that free fatty acids play an important role in insulin
resistance. However, the mechanism for this is uncertain.
A study was conducted in a group of obese and lean Caucasian women to
investigate the relationship between insulin sensitivity and intra-muscular triglycerides
(mTG) and saturated free fatty acids. There was a negative correlation of mTG and
insulin mediated glucose uptake in obese women when compared to controls. Saturated
fatty acids were higher in obese women than in controls. Increased mTG with saturated
fat decreased the rate of glucose uptake in obese women159.
Deposition of fat in the thigh region is also a marker of insulin resistance in obese
subjects with type-2 diabetes146. Mid thigh adipose tissue measured by tomography was
divided in to three compartments in obese and lean subjects. They were subcutaneous
adipose tissue (SCAT), adipose tissue beneath fascia (SFAT), adipose tissue infiltrating
muscle groups. Adipose tissue around and between the skeletal muscle strongly
correlated to insulin resistance along with adipose tissue beneath the fascia160.
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Insulin Resistance And Cardiovascular Disease Risk
Insulin resistance measured by euglycemic insulin clamp glucose disposal rate is
predictive of congestive heart failure26. The severity of coronary heart failure was
assessed by peak (VO2max), an index of cardiopulmonary function derived from maximal
exercise test in men with chronic heart failure, coronary heart disease and in controls161.
Chronic heart failure progressed with a marked increase in insulin resistance and reduced
peak Vo2.
In the San Antonio Heart Study which was in conducted in Mexican-Americans
and Non-Hispanic white women for a period of four years, HOMA-IR was positively
associated with anthropometric measures and cardiovascular risk factors such as HDL,
cholesterol, triglycerides, systolic and diastolic blood pressure162.
In the Strong Heart Study of American-Indian communities, the relation of insulin
resistance to echocardiographic markers of cardiovascular disease was studied. Simone
et al.163 measured insulin resistance by HOMA IR, left ventricular mass, left Ventricular
functioning, stroke volume/pulse pressure ratio and arterial compliance. Insulin
resistance was significantly associated with decreased arterial compliance in both men
and women.
The Framingham study of women free of myocardial infarction was examined for
the relationship between insulin resistance and echocardiogaraphic left ventricular
measurements. It was observed that left ventricular mass and left ventricular wall
thickness correlated positively with HOMA-IR in women when compared with men. This
is due to an increase in HOMA-IR with increased obesity in women164.
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The study on women was conducted by Folsom et al.165 in a cohort of middle
aged women from four U.S communities. Fasting insulin levels were measured in these
groups. The subjects developed coronary heart disease after 4-7 years of their study.
There was a positive correlation between coronary heart disease and fasting insulin.
Fasting insulin was a risk factor for coronary heart disease in black and non-black middle
aged women.
In addition, a study was conducted in a group of 15,000 men and women to
investigate the relationship between elevated fasting insulin levels and incidence of
ischemic stroke. The subjects were for 6-8 years for the incidence of ischemic stroke.
Fasting insulin levels and waist to hip ratios were determined in this cohort. The
incidence of ischemic stroke correlated with elevated levels of insulin and higher waist to
hip ratios166. This study agrees with an earlier report by Laakso 167 who reported that
fasting insulin levels is a good marker of insulin resistance in non-diabetic subjects.
Some studies have also not shown any significant correlation of insulin resistance
measured by euglycemic/hyperinsulinemic clamp and oral glucose tolerance test with the
development of cardiovascular disease168, 169.
Relationship Between Leptin And Insulin Resistance
In population based studies, serum leptin concentrations have been observed to
correlate with insulin sensitivity. De Courten et al.170 in his study of western Samoans
observed that serum leptin concentrations positively correlated with insulin resistance as
measured by oral glucose tolerance test clamp, BMI, fasting insulin and mean blood
pressure.
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Doehner et al.171 conducted a study to investigate the relationship between insulin
resistance, norepinephrine, TNF-alpha and hyperleptinaemia. The study compared
patients with chronic heart failure with healthy subjects. There was an inverse correlation
of insulin sensitivity and leptin levels in subjects with chronic heart failure. Thus it is
suggested that elevated leptin levels would directly and independently predict insulin
resistance in subjects with ischemic heart disease.
WAIST CIRCUMFERENCE
Waist Circumference
The sex-specific waist circumference cutoff points used by the NIH are a WC of
102 cm (40 inches) in men and 88 cm (35 inches) in women. Patients are categorized
according to their cut off points to be normal when WC is below 102 cm and high above
102 cm for men. Women are categorized to be normal with a WC of 88cm and high
when the WC is above 88 cm 172.
In the Third National Health and Nutrition Survey(1988-1994), subjects were
classified by BMI and waist Circumference in accordance with NIH guidelines, Subjects
with WC values greater than the cut off points(WC >102 for men and WC >88cm for
women) had hypertension, diabetes, dyslipidemia and metabolic syndrome compared
with normal subjects with WC values below the cutoffs. Subjects with increased WC
values showed greater health risk for heart disease173.
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Some authors have suggested a graded system for the assessment of health risk
using WC. Han et al.28 determined the frequency of cardiovascular risk factors in a
random sample of men and women and proposed that WC values less than 94cm in men
and of less than 80 cm in women were at low health risk. Those ranging from 94 to 102
cm in men and 80 to 88 cm in women were of moderate health risk. Those greater than
102 cm in men and greater than 88 cm in women have a health risk for cardiovascular
disease. When cardiovascular risk factors such as systolic and diastolic blood pressure,
total plasma cholesterol concentration were measured, men and women with waist
circumferences exceeding 94 cm and 80 cm respectively had one cardiovascular risk
factor.
Waist circumference is correlated with obesity and cardiovascular disease risks
more than BMI. Obesity related risks such as low HDL, high LDL, high blood pressure,
and high glucose values were more strongly associated with WC than BMI in a cohort of
white men and women. A WC of 90 cm for men and 83 cm for women corresponded to
an equivalent in risk of BMI of 25, whereas a WC of 100 cm for men and 93 cm for
women was equivalent in risk to BMI of 30 174.
Lofgren and his colleagues27 conducted a study in a cohort of overweight or obese
premenopausal women. The association of biomarkers for coronary heart disease with
waist circumference and BMI was evaluated. Plasma biomarkers such as lipids,
apolipoproteins, LDL peak diameter, LDL susceptibility to oxidation, glucose, leptin and
insulin were measured. A strong positive correlation between BMI and WC was
observed. A majority of the subjects who had a BMI < 30 Kg/m2 had a WC>88 cm (92.6
± 3.7 cm). The subjects with WC > 88cm had higher diastolic pressure, higher plasma
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TG and apo C-III concentrations which are associated with coronary heart disease.
Although, BMI also showed a positive correlation with all the risk factors in these
subjects, WC in these subjects showed stronger association with coronary heart disease.
This suggest that WC can be used as reliable tool to assess the risk for coronary heart
disease27. This finding is consistent with another study conducted by Janssen and
colleagues175 who found that WC alone was a better predictor of cardiovascular disease.
Thus for a given value of Waist circumference in overweight and obese person and
normal weight persons, there is an increase risk for cardiovascular disease.
Waist circumference is an indirect measurement of abdominal fat which includes
both visceral and subcutaneous fat. In the 1981 Canada Fitness Survey, the relationship
of cardiorespiratory fitness (CRF) with waist circumference, sum of trunk skin folds (an
index of central adiposity) and sum of five skinfolds, (an index of abdominal adiposity)
was examined. Cardio respiratory fitness was measured by maximal oxygen uptake
(VO2max) during an exercise test. Higher cardio respiratory fitness was strongly
associated with lower waist circumference for a given BMI. Lower sum of trunk
skinfolds and sum of five skinfolds were observed in groups with high CRF176. Janssen
et al.177 determined the correlation of abdominal and non-abdominal fat to waist
circumference and BMI in a cohort of white men and women. Waist circumference was
independently correlated with abdominal fat, non-abdominal fat and visceral fat in obese
men and women. It was observed that an increase in waist circumference with increasing
abdominal fat is specifically contributed by visceral fat. The ability of waist
circumference to predict obesity related health risk is explained by visceral fat.
37
According to Mosca et al.178 WC can be used as a surrogate measurement for
cardiovascular disease risk in women because it is highly correlated with the global
Framingham risk score, cardiovascular disease and diabetes. These findings are
consistent with the findings of Kato et al.179, who conducted a study in a cohort of 62
female patients with schizophrenia. An increased waist circumference was associated
with cardiovascular risk factors such as hypertension, dyslipidemia, abdominal serum
glucose. Waist circumference is a non-invasive, economical and practical tool for the
identification of women with risk for cardiovascular risk.
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CHAPTER III
METHODOLOGY
Hypothesis
The following hypotheses were formulated for this study:
1. There is an ethnic difference between leptin levels, insulin resistance and waist
circumference in American Indian an African American women.
2. Blood leptin concentration is positively correlated with age, systolic blood
pressure and total cholesterol in American Indian and African American women.
3. Insulin resistance (Homa-IR) is positively correlated with age, systolic blood
pressure and total cholesterol in American Indian and African American women.
4. Waist circumference is positively correlated with age, systolic blood pressure and
total cholesterol in American Indian and African American Women.
5. Waist circumference will be positively correlated with Insulin resistance (Homa-
IR) in both ethnic groups.
Assumptions And Limitations
Several assumptions have been made in order to proceed with this analysis. The
first assumption is that subjects were truthful with the information they provided. The
second assumption is that HOMA IR is a valid measure of insulin resistance in AI and
and AA women. The third assumption is that the subjects in the study were truly fasting
when blood samples were taken. The fourth assumption is that all the subjects were
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similar in that they did not have any underlying condition or health problem that might
confound the outcomes. The final assumption is that results of lab analysis were accurate.
Potential limitations for this design include missing data because not all values for
each subject may have been obtained. In addition, the sample is a convenience sample
based on their availability and willingness to participate. Therefore, this is not a random
selection of subjects. This sample is a not a representative sample of the whole
American Indian and African American population but is a good representation of
American Indian and AA women from rural Oklahoma.
Primary Data Collection Methods
Data was collected by researchers and trained staff at local community centers,
clinics and tribal complexes between May, 2001 to Spetember, 2002 .
Eighty one women were recruited from the local communities of Binger, Boley,
Anadarko, Langston, Wewoka, El reno and Lawton . Local contact persons such as
tribal leaders, community center staff, extension specialists and medical clinic workers
assisted with distributing information regarding the health study eligibility
requirements and with recruiting of participants. Written consent to participate in the
study was obtained in accordance with the guidelines of the Institutional Review Board
for Human Research at Oklahoma State University and Langston University.
Inclusion And Exclusion Criteria
Women of child bearing age were included in the study. Subjects who were
missing more than 25% of data were excluded. After consent was obtained, fasting
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venous blood samples were drawn by licensed phlebotomists. Anthropometric
measurements include weight, height, triceps skin fold thickness, and bioelectric
impedance assessment (BIA) of body compositions were done by the same person to
maintain precision. Finally, the women were interviewed by research staff to obtain
information on diet, lifestyle habits, and socioeconomic background.
Anthropometric Measurements And Body Composition Determination
Standing barefoot height was obtained for each participant using a portable
stadiometer, Seca model 214 Road Rod, (Seca Corporation, Hanover, MD). Weight and
body composition were then measured utilizing a bioimpedance scale(Tanita Body
Composition Analyzer/Scale Model TBF-310,Tanita Corporation of
America,Inc.,Arlington Heights,IL). Body mass Index was calculated as Kg/m2.
Midarm circumference was measured using nonstretch tape on the non-dominant arm
midway between the acromion process and tip of olecranon. Triceps skin fold
measurement was done on the posterior side of the non-dominant arm. It was measured
over the triceps muscle and the midway between the acromion of scapula and olecranon
of the ulna. On the lateral side of the arm, the midpoint of acromion and olecranon was
marked with the elbow placed at 90 degrees. The skinfold was grasped by the measurer
with the thumb and index finger of the left hand. The tip of the caliper was about 1cm or
0.5 in. from the thumb and finger. The caliper was placed perpendicularly to the long
axis of the cylinder and 3 readings were noted down from the dial and averaged (Lange
skin fold caliper operation manual, Beta technology Inc., Santacruz, CA, U.S.A). Waist
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circumference was measured by locating the navel and a non stretch tape was placed
around the abdomen without compression on the skin.
Biochemical Analysis
Leptin concentrations were determined using an enzyme linked immunoassay
(ELISA) Kit (Linco Research, St.Charles, Missouri). Human leptin molecules from
samples were captured on the pretreated plates. These molecules are transferred to a
microtiter plate coated by polyclonal rabbit anti-human leptin molecules. Unbound
materials from the samples were removed by washing with the buffer. Biotinylated
monoclonal antibodies were added to bind the captured human leptin, after which
alkaline phosphatase was added to the biotinylated antibodies. The immobilized antibody
enzyme conjugates were quantified by monitoring alkaline phosphatase activity in the
presence of substrate p-nitrophenyl phosphate. The enzyme activity was measured
spectrophotometrically by the increased absorbency at 405 nm. Increased absorbency is
proportional to the amount of captured human leptin in the participants’ samples.
Serum insulin concentrations were determined by radioimmunoassay (RIA) kit
(Linco Inc). A fixed concentration of labeled tracer antigen was added to the samples
taken from participants. The antiserum was then added and incubated with a mixture of
sample antigen and radio-labeled antigen. Due to limited binding sites on the antibody,
the unknown antigen reduces the amount of available tracer antigen that may bind to the
antibody. The fractions of bound and free labeled antigen (insulin) were measured to
determine the amount of insulin in the unkown sample. In this assay I-labeled human
insulin and human insulin anti-serum was used. The calculation for the amount of human
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insulin present in each sample was automatically performed by gamma counter at
Oklahoma state University’s Human Nutrition Laboratory.
Colorimetric assays of fasting serum glucose, total cholesterol, HDL cholesterol,
and triglycerides were performed on a Roche Cobas Fara Centrifugal Analyzer (Roche,)
using commercially available kits.
Estimation Of Insulin Resistance By HOMA (Homeostasis Model Assessment)
Matthews et al.180 developed a mathematical model to predict the homeostatic
concentrations of glucose and insulin beta-cell deficiency in varying states of insulin
resistance. The quantitative assessment of insulin resistance was done utilizing fasting
insulin and glucose concentrations (HOMA) using the following mathematical formula:
(HOMA IR) = Ln (Fasting Insulin * Fasting Glucose /22.5)
Fasting Insulin units are in µU/mL and Fasting Glucose in mg/mL.
HOMA has been validated as a reliable predictor of insulin resistance in humans.
The estimation of insulin sensitivity by HOMA is significantly and highly correlated with
other measures of insulin sensitivity such as hyperglycemic and euglycaemic clamps and
intravenous glucose tolerance test. It must be noted that HOMA is merely an estimation
of insulin resistant state and not as sensitive or precise as the clamp technique. It is
however, less invasive, less time consuming, less costly, requires less personnel and
equipment180-185.
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Normal Values
Normal leptin levels for lean women ranges from 7.4±3.7ng/ml. Normal blood
pressure is 120/80 mm Hg. HDL-C ranges from 40-60 mg/dL. Normal total cholesterol
is expected to be less than 200 mg/dL. Normal fasting insulin levels are expected to be
between 6.0-27.0µU/ml and normal fasting glucose levels at 70-110mg/dL. Normal
HOMA IR values are expected to range from 1.45-2.8.
Statistical Analysis
Statistical Analysis Software for Windows (SAS 9.1.3 Version, Cary, and N.C)
was used to analyze all data. Proc GLM was used to compare differences between
American Indian and African American groups. The GLM procedure was used because
there are unequal numbers of observations in both groups.
Pearson’s Correlation coefficients were used to determine the relationship of
cardiovascular risk factors with leptin insulin resistance and waist circumference using
PROC CORR procedure of SAS.
The chi-square statistic was used to compare the frequency counts of number of
smokers with non smokers in both the groups.
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CHAPTER IV
CARDIOVASCULAR RISK FACTORS IN AMERICAN INDIAN AND AFRICAN
AMERICAN WOMEN OF CHILD BEARING AGE AND THE RELATIONSHIP OF
THESE FACTORS BLOOD LEPTIN CONCENTRATION, INSULIN RESISTANCE
AND WAIST CIRCUMFERENCE
Context
Prevalence of health disparities among racial/ethnic groups especially the
prevalence of cardiovascular diseases is a major concern in the nation. Leptin
concentrations, insulin resistance, and waist circumference are predictors of
cardiovascular disease incidence in American Indian and African American women.
Objectives
To determine if there is an ethnic difference in leptin levels, insulin resistance and
waist circumference between AI and AA women and to examine the relationship of these
variables with cardiovascular risk factors in this cohort.
Design, Setting and Participants
Prospective epidemiologic study of 81 women (48 AI, 33 AA) of child bearing
age from rural Oklahoma. Participants were recruited by convenience sampling from the
local communities of Andarko, Binger, Boley, El Reno, Langston, Lawton and Wewoka
in Oklahoma between May, 2001 to September, 2002.
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Main Outcome Measures
Differences in leptin levels, insulin resistance (HOMA IR), and waist
circumference in this cohort and correlation of these variables with age, systolic blood
pressure, waist circumference and total cholesterol.
Results
Ninety percent of the women were overweight or obese with a mean BMI of 33
Kg/m2. Of the AI women, 58% were obese and of the AA women, 61% were obese.
Leptin levels were significantly different between the two ethnic groups. Leptin
concentrations were significantly higher for AA women when compared to AI women.
There was no significant difference in waist circumference and insulin resistance
measures between these groups. There was a positive correlation of leptin with systolic
blood pressure in both groups (r=0.33, p= 0.004) and waist circumference with systolic
blood pressure (r=0.26, p=0.02) in both groups.
Conclusion
African American women had greater leptin concentrations when compared to AI
women. Obesity and overweight were prevalent in this cohort. Blood leptin
concentration and waist circumference were correlated with cardiovascular risk factors in
AI and AA women of child bearing age. Insulin resistance estimated by HOMA IR was
not correlated with cardiovascular risk factors. However HOMA IR correlated with waist
circumference and waist circumference correlated with SBP.
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Introduction
Cardiovascular disease is major public health concern in the United States with an
estimated health care cost of over $300 billion annually due to disability and death1. It is
estimated that over 71 million adults in the U.S, or 1 in 3 live with some form of
cardiovascular disease 1. According to the CDC, heart disease and stroke are the
principal components of cardiovascular disease and accounts for up to 40% of all deaths
in the nation2. Cardiovascular disease is the leading cause of death in both genders
among racial and ethnic groups3. Heart disease is the leading killer of minority women in
the United States4. According to the Framingham risk score, risk factors that increase the
likelihood of developing cardiovascular disease are age, gender, systolic blood pressure,
HDL cholesterol, total cholesterol, and smoking 5.
Of all the minority groups, African American women tend to develop high blood
pressure at a younger age6. They are also less likely to engage in physical activity
resulting in obesity and diabetes. The prevalence of obesity is high among AA women.
A Montana study has shown that American Indians are at a higher risk of developing
cardiovascular disease compared to whites7. American Indian women develop obesity
and overweight at a very earlier stage. This is due to an excess accumulation of fat in
childhood among AI’s8.
Cardiovascular disease is the leading rankable cause of deaths in Oklahoma
among AI and AA women. Overall, this accounts for 40% all deaths in United States and
44% of all deaths in Oklahoma9. In Oklahoma, the age adjusted death rate due to heart
disease was higher in African Americans when compared to American Indians between
1991-1995. The likelihood of women in Oklahoma dying from heart disease is 50%
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higher than from cancer10. Coronary heart disease accounts for one in five deaths in
women in Oklahoma and was also the leading cause of death among females in
Oklahoma in 200311. In addition, risk factors such as smoking, high blood pressure,
obesity and inactive lifestyle are a problem in Oklahoma. It was calculated that of heart
disease deaths among women in Oklahoma smoking accounted for 25%, obesity
accounted for 32%, sedentary lifestyle accounted for 35% and high blood pressure
accounted for 29% of heart disease deaths12.
Human obesity is characterized by an increase in serum leptin concentrations
associated with an increase in leptin mRNA concentration in adipose tissue as well as an
increase in total body fat13-15. Leptin has been shown to increase arterial pressure and
blood pressure in obese subjects16, 17. Furthermore, it has been reported that leptin is
positively correlated systolic blood pressure (SBP) and pulse pressure in hypertensive
obese/overweight African women18. In addition, in women with android type of obesity
serum leptin levels were significantly higher19 than women with gynoid obesity.
Researchers have proposed that the heredity and genetics influence the propensity for
developing heart disease in AI and AA20.
Insulin resistance is predictive of congestive heart failure and is associated with
more severe disease and prognosis21. Abdominal body fat is closely associated with
insulin resistance and decreased glucose disposal rate in obese patients22, 23. Waist
circumference which is a measure of abdominal obesity is a predictor of coronary heart
disease in women24, 25.
In this study, it was hypothesized that differences existed in leptin levels, insulin
resistance and waist circumference exist between AI and AA women and that these
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variables were correlated with cardiovascular risk factors in this cohort of women of
child bearing age.
Methods
Design and Study Cohort
A community based sample of AI and AA of child bearing age, were recruited
from rural Oklahoma communities of Anadarko, Binger, Boley, El Reno, Langston,
Lawton, and Wewoka, Oklahoma. Written consent to participate in the study was
obtained in accordance with the guidelines of the Institutional Review Board for
Human Research at Oklahoma State University and Langston University. Data was
collected by researchers and trained staff at local community centers ,clinics and tribal
complexes between May,2001 to September,2002. Inclusion criteria were AI or AA
women with age between 22 and 45 with children. Subjects with a BMI greater than 52
(outliers) were excluded in this study and subjects who were missing more than 25% of
data were excluded.
Anthropometric Measurements and Body Composition Determination:
Standing barefoot height was obtained for each participant using a portable
stadiometer, Seca model 214 Road Rod, (Seca Corporation,Hanover,MD). Weight
and body composition were then measured utilizing a bioimpedance scale(Tanita
Body Composition Analyzer/Scale Model TBF-310,Tanita Corporation of
America,Inc.,Arlington Heights,IL). Body mass Index (Kg/m2) was calculated. Waist
circumference was measured in the location of the navel with a non stretch tape placed
around the abdomen without compressing the skin.
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Biochemical Analysis:
Fasting blood samples were drawn, placed on ice, transported to the lab,
processed, and stored on the same day. Leptin concentrations were determined using an
enzyme linked immunoassay (ELISA) Kit (Linco Research, St..Charles, Missouri).
Serum insulin concentrations were determined by radioimmunoassay (RIA) (Linco Inc).
Colorimetric assays of fasting serum glucose, total cholesterol, HDL cholesterol, and
triglycerides were performed using a Roche Cobas Fara Centrifugal Analyzer (Roche)
and commercially available kits.
Formula and normal values
The normal fasting range of leptin for lean women ranges with BMI of 18-25 is
7.4±3.7ng/ml (Linco Kit). Normal fasting insulin levels are expected to be between 6.0-
27.0µU/ml and normal fasting glucose levels between 70-110mg/dL. Waist
circumference cutoff is 88 cm (35 inches) in women26 (NIH). Normal blood pressure is
120/80 (AHA). Normal HDL- cholesterol level ranges from 40-50mg/dL (AHA).
Glucose and insulin concentrations were used in calculating the HOMA-IR, as an index
of insulin sensitivity which was calculated as follows27.
HOMA IR=ln [insulin(µU/mL)*glucose(mg/mL)/22.5]
Normal expected values for HOMA –IR ranges from 1.45-2.8. As HOMA-IR value
increase, insulin resistance increases.
Statistical Analysis:
Statistical Analysis Software for Windows (SAS 9.1.3 Version, Cary NC) was
used to analyze all data. Proc GLM was used to compare differences between AI and AA
women. Pearson’s Correlation coefficients were used to determine the relationship of
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cardiovascular risk factors with leptin insulin resistance and waist circumference. The
chi-square statistic was used to compare smoking frequency between both the groups.
Results
Of the 81 subjects, there were 33 AA and 48 AI women. Table 1 lists values for
the variables from each ethnic group. No significant difference was observed between
the groups for age, BMI, waist circumference, total cholesterol, HDL cholesterol, systolic
blood pressure, HOMA IR, and, percent body fat listed in (Table.2). Mean age was 34 ±
5 years (Table.2).Mean BMI was 33.2 ± 7.3. Mean waist circumference was 107.2 ±
17.3 (centimeters). Mean total cholesterol was 195.9 ± 40.8 mg/dL. Mean HDL
cholesterol was 49.9 ± 16.4 mg/dL. Mean SBP was 125.9 ± 12 mmHg. Mean HOMA IR
was 5.0 ± 0.9. Mean percent body fat is 42.8 ± 7.5 (Table 1)
Leptin levels were significantly different between the two ethnic groups.
Concentrations were significantly higher for AA women when compared to AI women
(Table.1). No significant difference was observed in waist circumference and insulin
resistance (HOMA IR) between the ethnic groups although fasting glucose levels were
significantly higher in the AI women. Leptin concentrations correlated with indices of
body fatness including waist circumference in both ethnic groups. More noticeably,
HOMA IR and leptin concentration were significantly correlated in both groups (AI,
r=0.56, p=<0.01, AA, r=0.57, p= 0.01). HOMA IR was also significantly correlated with
BMI, waist circumference (r=0.45, p=<0.01), and percent body fat in both groups but not
with systolic blood pressure. HOMA IR significantly correlated with serum triglycerides
in both groups (r= 0.26, p=0.02).
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Correlations between leptin concentrations and age, systolic BP, HDL, total
cholesterol are in Table.3. In both AI and AA women, leptin concentrations had
significant positive correlation with systolic blood pressure (r=0.33, P=0.01) (fig.1).
There was no significant correlation of leptin with age, HDL-C and total cholesterol in
these women.
No significant differences in waist circumference and insulin resistance were
observed between both groups. Table.4 gives the bivariate correlation coefficients for
waist circumference and insulin resistance with age, SBP, HDL C and total cholesterol in
both groups. There was no significant correlation between HOMA IR and HDL-C or
total cholesterol. The relationship of waist circumference with HDL-C and total
cholesterol was not statistically significant in both groups. Waist circumference was
significantly correlated with systolic blood pressure (r=0.27, p=0.02) (fig.2).
Significantly more AI women smoked than AA women. Fifty one percent of AI women
and eighteen percent of AA women were smokers.
Comment
This study was designed to determine differences in leptin levels, insulin
resistance and waist circumference between AI and AA women of child bearing age from
rural Oklahoma and to determine the relationship of these variables to cardiovascular risk
factors such as age, SBP, HDL-C and total cholesterol. It must be noted that, the number
of smokers in AI women were higher when compared to AA women and places these
women at high risk for cardiovascular disease. Serum leptin and insulin concentrations
were above normal values for both groups as well.
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This study highlights an important difference in the levels of leptin concentration
between AI and AA women of Oklahoma. Despite similarities in waist circumference,
BMI and percent body fat, the leptin levels were higher for AA women when compared
to AI women. Studies have shown an association between serum leptin concentrations
with percent body fat as a major contributor to increased leptin concentration14, 15, 28.
Increased subcutaneous fat29is also associated with increased leptin concentrations. In
AA women, the midarm circumference and triceps skinfold measurements was also
greater compared to AI women. The Tanita scale may not have been sensitive to body fat
in these women. In our group, it is possible that AA women had more subcutaneous fat
than AI women. We found positive correlations between SBP and leptin in both the
groups. But the correlation was low and there was no difference between SBP among AI
and AA women. Schutte et al.18 found a significant relationship between leptin levels
and SBP in hypertensive obese African women when compared to normotensive lean
controls. Elevated plasma leptin levels have been shown to exist in women with android
obesity and positively correlated with ambulatory 24-hour systolic blood pressure19. In
our study, correlation outcome may be because AI and AA women were more sensitive
to the action of leptin in their response to sympathetic nervous system response. The
possible mechanism that links leptin levels and SBP in obesity may be the action of leptin
on the central nervous system activity30.
In this study, HOMA IR (insulin resistance) was significantly correlated with
indices of body fatness such as BMI, WC, and percent body fat in both groups. Insulin
resistance in obesity is characterized by a strong correlation between insulin levels and
degree of obesity 31. Abdominal body fat is closely associated with insulin resistance23.
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Carey et al.22 have shown that abdominal subcutaneous fat as well as visceral body fat is
positively correlated with insulin resistance in obese women. The majority of women in
this study had waist circumference greater than 88 cm with a mean WC of 107 cm.
Despite differences in leptin concentrations in AI and AA women, HOMA IR and leptin
positively correlated in both groups. Doehner et al.32 observed an inverse correlation of
leptin levels and insulin sensitivity in subjects with chronic heart failure. Elevated levels
of leptin directly predict insulin resistance in ischemic heart disease33. Thus it is
suggested that an interrelationship of body fatness, leptin levels and HOMA IR may
result in the development of heart disease in our cohort.
There were no associations between insulin resistance and age, SBP, HDL-C and
total cholesterol. However there was significant correlation between HOMA IR and
serum triglycerides. In a study conducted in obese and lean Caucasian women, elevated
triglycerides were negatively correlated with intramuscular triglycerides and insulin
mediated glucose uptake in obese women when compared to controls34.
In the present study, waist circumference (WC) positively correlated with SBP in
both groups which are in agreement with the finding of Third National Health and
Nutrition Survey (1988-1994)35. Han et al.25 observed women with a WC greater than
80 cm was a predictor of cardiovascular risk factors such as high blood pressure, total
cholesterol, high LDL, low HDL and high glucose values than BMI alone. Waist
circumference is correlated to obesity and is a strong predictor of cardiovascular risk in
obesity35, 36. Results of this present study are in agreement with Lofgren et al.24 who
observed a positive association of waist circumference with coronary biomarkers such as
high blood pressure and serum triglycerides in overweight or obese premenopausal
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women suggested that waist circumference is a more reliable tool to assess risk for
coronary heart disease than BMI. However, in our cohort there was no association
between waist circumference and age, HDL-C or total cholesterol. Thus, it may be
suggested that waist circumference is a non-invasive, economical and practical tool for
the identification of subjects with risk for cardiovascular risk.
Strengths And Limitations
This is a study of the differences between two ethnic minority groups for leptin,
insulin resistance and waist circumference and the relationship of these variables to
cardiovascular risk factors in these groups who face major health challenges. We only
examined women of child bearing age with a similar ethnic and socio-economic
background within the state of Oklahoma. In addition, this study is a convenience sample
based on participant’s willingness and availability to participate. It is not a representative
sample of the whole American Indian and African American population but is a good
representation of AI and AA women from rural Oklahoma.
Conclusions
Ninety percent of women in this cohort were overweight or obese. Leptin
concentrations were significantly greater in AA women. But blood leptin concentration
was correlated with SBP in both AA and AI women suggesting a phenotypic difference
in the etiology of and the involvement of leptin in the development of cardiovascular
disease. Mean waist circumference places this cohort at risk for heart disease. Waist
circumference was correlated with SBP in both AI women and AA women. As well,
mean SBP was above normal and in the pre-hypertensive classification with mean waist
circumference above the cut off of 88 cm. The AI and AA women of child bearing age in
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this study were already at high risk for cardiovascular disease. Interventions to reduce
BMI and waist circumference in these women are imperative especially since the onset
menopause further increases the risk for heart disease.
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Table 1: Mean values for AI and AA women 22-45 years of age
Variable AA Women
N=33
mean±std.deviation
AI Women
N=48
mean±std.deviation
Age 34.4±5.7 (26-45) 34±5.9 (22-45)
Height 64.7±2.4 (61-71) 64.8±1.6 (61-67)
Weight 206.9±54.7 (111-346) 193±38.7 (107-300)
Body Mass Index 34.6±8.2 (18-50) 32.3±6.5 (18-52)
*MAMC 37.1±7.1 (27-59) 33.1±4.4 (24-46)
*Tricep Skin Fold 36.5±9.7 (17-54) 32.2±7.8 (13-48)
Hip 119.7±18.4 (83-150) 117.1±13.1 (92-150)
Waist 108.7±21.6 (69-150) 106.2±13.9 (77-145)
FFM 111.8±14.7 (88-145) 109.4±12.7 (83-138)
Percent body fat 43.9±8.5 (20-58) 42±6.6 (22-54)
Systolic 128.5±13.8 (100-160) 124.2±12 (97-145)
Diastolic 83.3±8.3 (60-100) 80.7±9.4 (58-100)
*Serum glucose 98.6±17.4 (60-161) 112.5±33.1 (63-262)
Serum total cholesterol 194.7±35.5 (105-272) 196.7±44.4 (70-274)
Serum HDL 52.9±16.5 (18-87) 47.9±16.1 (17-87)
*Serum triglycerides 95.5±56.6 (1-283) 145.6±91.7 (12-476)
*Leptin 35.6±17.3 (5-79) 28±12.3 (4-60)
Insulin 55.3±58.8 (4-269) 41.6±34 (5-171)
HOMA IR 4.9±1 (2-7) 5±0.79 (3-6)
Waist hip 0.8±0.08 (0.6-1.4) 0.9±0.06 (0.75-1.08)
*p<0.05, Significant difference between AI and AA women
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Table: 2 Descriptive statistics for all women
Variables Mean
N=81
Std.deviation
N=81
Min Max Mode
Age 34 5.79 22 45 30
BMI 32 7.3 18 52 29.75
Waist Circum(cm) 107.2 17.3 69 150 106
Total Chol(mg/dL) 196 41 70 274 175
HDL Chol(mg/dL) 50 16 17 88 45.7
SBP(mm/Hg) 126 13 97 160 120
HOMA IR 5 0.92 3 7 -
Percent body fat 43 7 20 58 40.9
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Table: 3 Correlation between leptin and cardiovascular risk factors in AI and AA
women
Variables r value P value
Age -0.13931 0.40490
Systolic blood pressure 0.33492 0.0043
HDL 0.01886 0.8682
Total Cholesterol 0.02460 0.8286
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Table: 4 Correlation between waist circumference and insulin resistance in AI and
AA women
Waist Circumference HOMA IR
Variables r value p value r value p value
Age 0.12741 0.2570 -0.01052 0.9267
Systolic blood
pressure
0.26887 0.0224 0.12076 0.3194
HDL -0.14742 0.1896 -0.07365 0.5189
Total cholesterol -0.06140 0.5861 0.06008 0.5989
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Figure 1: Correlation of Leptin and Systolic Pressure in both ethnic groups
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Figure 2: Correlation of Waist Circumference and Systolic Blood Pressure in both
ethnic groups
Correlation of Waistcircumference and Systolic Blood
pressure in both ethnic groups
0
20
40
60
80
100
120
140
160
180
0 20 40 60 80 100 120 140 160
Waist Circumference(Cms)
Sy
st
o
lic
B
lo
o
d
Pr
es
su
re
(m
m
H
g)
r=0.26887
p=0.0224
62
Figure 3: Correlation of waist Circumference and HOMA IR in both ethnic groups
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CHAPTER V
SUMMARY, CONCLUSIONS, AND RECOMMEDNATIONS
Summary
This study was designed to determine if ethnic differences exist between AI and
AA women in leptin levels, insulin resistance and waist circumference in ethnic groups.
The correlation of leptin levels, insulin resistance and waist circumference with
cardiovascular risk factors such as SBP, age, HDL and total cholesterol was also
determined. Finally, the correlation of waist circumference and insulin resistance was
determined for this population.
Similarities were observed between the two ethnic groups for age, body mass
index, waist circumference, percent body fat, HDL cholesterol, total cholesterol and SBP.
Leptin levels were significantly higher in AA women when compared to AI women.
There were no significant differences between the groups for insulin resistance and waist
circumference. Leptin levels positively correlated with systolic blood pressure in both
groups, although leptin levels were higher in AA women. Since no significant
differences were observed for insulin resistance and waist circumference, both groups
were combined and correlated with cardiovascular risk factors. Waist circumference
positively correlated with SBP. Waist circumference increased with increased in SBP.
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The relationship between waist circumference and insulin resistance was statistically
significant. Insulin resistance increased with increased in waist circumference.
Conclusions
The objectives of this study to determine ethnic differences between AI and AA
women and the relationship of leptin, insulin resistance and waist circumference to
cardiovascular risk factors. The following hypotheses were tested with related with
outcome.
Hypothesis I:
Thereis an ethnic difference between leptin levels, insulin resistance and waist
circumference in American Indian and African American women.
Outcome I:
In this study, there was a significant difference (p <.05) between American Indian and
African American women for leptin levels when compared to insulin resistance and waist
circumference.
Hypothesis II:
Blood leptin concentration is positively correlated with age, systolic blood pressure and
total cholesterol in American Indian and African American women.
Outcome II:
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Although African American women had significantly greater serum leptin concentrations
when compared to American Indian women, a significant relationship (p=0.03) between
SBP and American Indian and African American women was exhibited.
Hypothesis III:
Insulin resistance (Homa-IR) is positively correlated with age, systolic blood pressure
and total cholesterol in American Indian and African American women.
Outcome III:
Insulin resistance did not correlate with any of the cardiovascular risk factors in
American Indian and African American women.
Hypothesis IV:
Waist circumference is positively correlated with age, systolic blood pressure and total
cholesterol in American Indian and African American Women.
Outcome IV:
There was a significant relationship between waist circumference and SBP in both groups
Hypothesis V:
Waist circumference will be positively correlated with Insulin resistance (Homa-IR) in
both ethnic groups.
Outcome V:
The relationship between insulin resistance and waist circumference was statistically
significant for both ethnic groups. An increase in insulin resistance marked an increase
in waist circumference.
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It may be suggested that leptin concentrations in American Indian and African
American women induce an increase in SBP due its effect on activation of sympathetic
nervous system causing vasoconstriction and increasing renal tubular sodium
reabsorption and inducing insulin resistance in obese subjects with increased body fat
distribution through its effect on insulin. It may also be hypothesized that waist
circumference is a better predictor of insulin resistance which is a major risk factor for
metabolic syndrome and related diseases of the heart rather than HOMA IR. In these
voluntary groups of participants greater BMI and SBP placed them at higher risk for
cardiovascular disease. Lack of physical activity among the ethnic groups is evident in
this cohort. This study gives an insight about the low socio-economic status strata in
rural Oklahoma. It is evident that these cohorts of women are high risk for heart disease
even before menopause.
Recommendations
Further studies should be conducted to determine the relationship of
adipocytokines products of adipose tissue such as adinopectin, resistin, tumor necrosis
factor (TNF-) with cardiovascular risk factors in minority women who are more likely
to be overweight or obese.
In this study, although leptin concentrations were higher in AA women when
compared to AI women, body fat content was similar. Difference in subcutaneous and
visceral fat between both groups should be studied. Further studies to determine the
subcutaneous and visceral fat and its association with risk factors for heart disease in
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minority women are recommended. Culturally appropriate interventions are highly
recommended to decrease smoking, promote exercise and healthy eating to control body
weight in AI and AA women especially Oklahoma. Waist circumference is a non
invasive, economical, and practical tool for the identification of women with risk for
cardiovascular risk. Further studies to investigate the relationship of leptin with
cardiovascular disease in various ethnic groups are recommended.
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Studies showing the normal values for insulin resistance calculation by HOMA IR180, 184,
186, 187
Authors (Year) Normal Values
Mean ± SD
(Range)
Diabetes or IGT
Matthews (1985) 1.45 2.61
Kanauchi (2002) 1.69 ± 0.84 3.19 ± 1.43
1.89 ± 1.50
Bonora (2000) 2.06 ± 0.14
(0.7 - 6.0)
5.98 ± 0.48
(1.1-13.9)
Ascaso (2001) 3.8 -
Yeni-Komshan (2000) 2.7 ± 0.1
0.2-14.6
-
92
APPENDIX C
93
The SAS System        10:09 Tuesday, February 28, 2006 197 
 
Participant                                        Tricep                       percbod 
Obs      ID       Ethnicity  Age  Height  Weight  MAMC    SF     Hip   Waist   FFM     FAT    systolic 
 
1 GP108         1       41   66.0    218.5  40.0   40.3   124.0  121.0  109.0    50.0      138 
 2 P108          1       26   65.5    165.5  30.5   29.6   103.0   87.0  103.0    37.9      140 
 3 P11           1       37   61.5    263.0  45.0   49.3   150.0  149.0  125.0    52.4      145 
 4 P18           1       32   63.5    217.0  38.5   42.0   117.0  109.5  117.0    46.2      110 
 5 P19           1       30   67.0    190.0    .      .    150.0   93.0  112.5    40.9        . 
 6 P193          1       30   63.5    166.5  33.5   41.3   112.0  105.0   96.5    42.1      118 
 7 P23           1       33   63.0    172.5  34.0   46.0   110.0   99.5  103.0    40.4      110 
 8 P24           1       30   63.5    227.0  38.0   38.0   130.0  114.0  112.0    50.7      122 
 9 P26           1       34   69.0    218.0    .    29.0   117.0   97.0  122.0    44.0        . 
 10     P27           1       43   62.0    195.0  30.5   42.0   124.0  122.5  104.5    46.3      100 
 11     P29           1       42   64.0    164.0  31.0   24.7   103.0   83.0  106.5    35.2      144 
 12     P31           1       44   65.5    215.5  39.0   38.3   126.0  112.0  121.0    43.9      140 
 13     P34           1       34   65.0    168.0  31.0   27.0   105.0  106.0   95.0    43.6      110 
 14     P39           1       32   63.0    253.0  37.0   43.0   135.0  104.0  122.5    51.6      133 
 15     P42           1       30   65.0    292.5  59.0   54.3   150.0  148.0  131.0    55.2      145 
 16     P43           1       44   63.0    111.0  32.0   17.5    83.5   69.5   88.5    20.3        . 
 17     P45           1       28   65.5    219.5  37.0   41.0   125.0  116.0  111.5    49.1      124 
 18     P60           1       38   66.5    284.5  45.0   46.7   142.0  143.0  133.0    53.3      138 
 19     P62           1       32   64.0    129.5  27.0   18.7    92.0   81.0   92.0    28.9      141 
 20     P63           1       45   64.5    167.5  31.0   32.0   110.0  103.0   97.5    41.7      120 
 21     P66           1       42   65.0    232.5  37.0   33.0   130.0  118.0  115.0    50.5      118 
 22     P67           1       31   67.5    183.0  30.5   33.3   104.0  100.0  107.5    41.3      130 
 23     P68           1       27   62.0    191.5  38.0   30.3   119.0  104.0  107.0    44.0      130 
 
ser 
Obs  diastolic  serglucose  stotchol   HDL  sertriglyc  leptin  insulin  waisthip    bmi     homair 
 
1 90         115        175    47.9       77      31.85    29.12   0.97581  35.3382  5.00284 
 2 84         101        122    35.3       69      17.85     7.80   0.84466  27.1767  3.55573 
 3 100         112        204    47.1       87      42.60    23.52   0.99333  48.9876  4.76283 
 4 80         108        175    63.1       71      29.61    36.43   0.93590  37.9134  5.16401 
 5 . 95        215    87.9       79      27.76    24.65   0.62000  29.8184  4.64514 
 6 84         102        179    50.3       94      38.60    24.58   0.93750  29.0903  4.71339 
 7 80          73        197    35.7       95      32.44    52.84   0.90455  30.6189  5.14421 
 8 92          84        161    45.9      178      58.56    45.37   0.87692  39.6606  5.13215 
 9 . 161        255    54.9      119      23.42    23.96   0.82906  32.2581  5.14427 
 10      60          94        235    69.7      119      37.76    17.17   0.98790  35.7382  4.27294 
 11      88         109        211    79.1       72      13.73    29.82   0.80583  28.2075  4.97301 
 12      90          60        105    18.8      187      25.17    47.27   0.88889  35.3872  4.83671 
 13      80          93        192    25.3      226      14.75     4.42   1.00952  28.0133  2.90522 
 14      82          92        248    71.6       46      58.10    43.18   0.77037  44.9077  5.17365 
 15      85         111        203    58.8       56      79.65    88.16   0.98667  48.7731  6.07517 
 16       .          79        178    60.2        1       5.29     6.86   0.83234  19.7026  3.18164 
 17      78          91        187    56.5       30      52.97    81.97   0.92800  36.0440  5.80370 
 18      92         119        194    39.6       76      55.49    30.78   1.00704  45.3231  5.09247 
 19      88          77        195    61.7       73        .       4.06   0.88043  22.2736  2.63147 
 20      90          99        244    76.1       48      23.12     9.75   0.93636  28.3646  3.75887 
 21      82          84        240    80.7       52      16.51      .     0.90769  38.7683   . 
 22      78         105        170    45.7      126      33.22   118.15   0.96154  28.2960  6.31240 
 23      84          94        142    41.6      149      46.73   160.89   0.87395  35.0967  6.51050 
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Participant                                        Tricep                       percbod 
Obs      ID       Ethnicity  Age  Height  Weight  MAMC    SF     Hip   Waist   FFM     FAT    systolic 
 
24     P69           1       34   62.0    264.5  43.0   42.00  146.0  129.0  122.0    53.9      140 
 25     P74           1       34   68.0    304.5  40.0   42.70  150.0  150.0  140.0    54.1      120 
 26     P76           1       33   62.5    152.5  34.0   42.30  101.0   91.0   97.0    36.4      120 
 27     P80           1       29   68.0    237.5  48.0   33.00  131.0  110.0  129.5    45.4      160 
 28     P81           1       32   61.0    141.0  29.5   27.00  104.5   82.0   93.0    33.9        . 
 29     P82           1       37   66.0    160.0  29.0   20.00  104.0   91.0  100.0    37.4      120 
 30     P83           1       33   66.0    231.0  37.0     .    122.0  118.0  126.5    45.3        . 
 31     P92           1       27   61.5    127.5  32.0   28.70   91.0   75.0   93.0    27.1      118 
 32     P94           1       44   64.0    216.0  43.0   50.00  122.5  113.0  112.0    48.2      128 
 33     P97           1       30   71.5    346.5  50.0   50.70     .   145.0  145.5    58.0      138 
 34     GP38          3       44   65.5    282.5  43.0   46.70  136.0  126.0  129.0    54.4      143 
 35     P1            3       31   64.5    206.0  33.0   32.00  121.0  105.0  138.5    32.7        . 
 36     P10           3       40   64.5    171.5  31.0   30.00  109.0   95.0   99.5    42.0      130 
 37     P100          3       31   66.0    217.0  35.0   35.30  126.0  115.0  118.5    45.4      132 
 38     P101          3       26   63.5    171.0  37.0   27.00  113.5  108.5   99.5    41.9      145 
 39     P103          3       33   65.0    149.0  28.0   27.30  102.0   90.0   95.0    36.4      120 
 40     P105          3       38   65.0    215.5  34.0   41.70  130.5  126.0  115.0    46.7      138 
 41     P106          3       23   64.5    236.0  37.5   33.00  136.0  116.0  115.5    50.8      142 
 42     P113          3       39   65.5    172.5  33.0   34.70  106.0  100.0  102.0    40.9      115 
94
43     P114          3       30   65.0    157.0  32.0   34.00   95.0   86.0  103.0    34.3      120 
 44     P115          3       35   64.0    163.0  30.0   30.30  109.0   96.0   97.0    39.6      120 
 45     P12           3       31   64.0    235.0  35.6   48.00  134.6  110.5  135.0    41.2      137 
 46     P13           3       40   67.0    188.0  31.5   27.30  106.0   98.0  110.0    41.6      125 
 
ser 
Obs  diastolic  serglucose  stotchol   HDL  sertriglyc  leptin  insulin  waisthip    bmi     homair 
 
24      90         103        176    42.0      127      54.32    78.89   0.88356  48.4756  5.88927 
 25      80          94        178    35.6       92      52.44   174.89   1.00000  46.3928  6.59394 
 26      82         115        191    31.0       87      18.60    45.06   0.90099  27.5037  5.43941 
 27      70          95        171    39.2       88      39.30    32.10   0.83969  36.1849  4.90922 
 28       .          91        211    63.7       49      18.77    16.46   0.78469  26.6956  4.19828 
 29      70         100        272    57.6      283      22.29   269.58   0.87500  25.8770  7.08852 
 30       .          91        205    60.9       65      32.88    53.08   0.96721  37.3598  5.36914 
 31      76          85        210    69.2       61      26.02     8.91   0.82418  23.7488  3.51631 
 32      84         110        190    42.5       76      47.99    49.16   0.92245  37.1514  5.48205 
 33      95         114        197    51.5       96      62.26   130.60    .       47.7499  6.49482 
 34      95         106        239    56.4      132      52.57    81.02   0.92647  46.3892  5.94462 
 35       .         114        252    18.8      204      22.90    35.47   0.86777  34.8842  5.19137 
 36      78          98        208    32.9      224      24.42    28.07   0.87156  29.0419  4.80615 
 37      90         101        183    52.1       64      30.54    19.53   0.91270  35.0956  4.47356 
 38      98         103        155    40.3      144      35.24    20.22   0.95595  29.8765  4.52789 
 39      76         104        189    36.3       93      11.43    11.59   0.88235  24.8451  3.98102 
 40      88         135        216    33.4      182      19.45    19.61   0.96552  35.9337  4.76780 
 41      90         101        186    59.1      101      51.44    61.95   0.85294  39.9644  5.62793 
 42      80          95        236    56.9       65      16.43    18.41   0.94340  28.3261  4.35326 
 43      80         135        158    25.3       68      13.01    11.55   0.90526  26.1791  4.23844 
 44      78          78        185    50.2       84      20.03    24.62   0.88073  28.0355  4.44675 
 45      88         159        107    29.3      177      22.43    42.60   0.82095  40.4193  5.70724 
 46      82         123        274    67.4       12      23.56    30.21   0.92453  29.5046  5.10684 
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Participant                                        Tricep                       percbod 
Obs      ID       Ethnicity  Age  Height  Weight  MAMC    SF     Hip   Waist   FFM     FAT    systolic 
 
47     P14           3       35   62.0    149.0    .    32.00  108.0   81.3  111.0    25.4        . 
 48     P16           3       30   63.0    162.0  30.0   30.30   97.0   96.0   97.0    40.1      122 
 49     P165          3       31   62.0    166.5  32.0   27.70  108.0  102.0  100.0    39.8      100 
 50     P22           3       30   63.5    269.5  35.0   47.70  145.0  122.0  129.5    51.9      120 
 51     P28           3       40   66.0    196.5  31.8   30.00  119.4  104.3  105.5    46.3      135 
 52     P3            3       38   65.0    189.5  33.0   41.00  115.6  104.0  105.0    44.5      115 
 53     P38           3       22   63.5    205.0  38.5   41.30  109.0  106.0  112.5    45.0      130 
 54     P44           3       24   67.0    174.5  28.0   23.00  114.0  107.0  104.0    40.3        . 
 55     P48           3       38   66.5    192.0  33.5   34.00  117.2   97.2  109.5    42.9      123 
 56     P5            3       41   66.5    200.5  34.5   38.00  112.0  109.0  111.5    44.3      110 
 57     P51           3       44   67.0    264.0  39.0   30.70  129.0  140.0  134.5    49.0      136 
 58     P52           3       40   67.5    218.0  33.0   29.30  129.0  124.0  113.5    48.0      115 
 59     P55           3       39   65.5    210.0  34.5   38.50  123.0  114.5     .       .       116 
 60     P59           3       38   64.5    177.5  28.0   28.70  112.0   99.0  102.0    42.6      145 
 61     P6            3       29   64.0    145.0  26.0   16.00  100.0   91.0   95.5    34.3      115 
 62     P61           3       37   63.5    176.5  32.0   29.70  116.0  106.0  101.5    42.4      135 
 63     P65           3       31   62.0    166.5  35.0   27.75  108.0  102.0  100.0    39.8      115 
 64     P7            3       33   67.0    190.0  30.0   22.00  115.0   99.0  111.5    41.2      118 
 65     P70           3       39   66.0    226.5  39.0   44.70  131.0  126.0  115.0    49.3      132 
 66     P71           3       23   65.0    168.5  33.0   34.00  115.0  108.0  102.0    39.5        . 
 67     P73           3       28   65.5    236.5  41.0   45.30  127.0  106.0  118.0    50.1      130 
 68     P75           3       36   64.5    107.5  25.0   13.70   92.0   83.0   83.5    22.5      112 
 69     P77           3       31   64.0    221.0  33.0   40.00  135.0  130.0  110.5    49.9      118 
 
ser 
Obs  diastolic  serglucose  stotchol   HDL  sertriglyc  leptin  insulin  waisthip    bmi     homair 
 
47       .         106        196    75.6      118      11.33    25.79   0.75278  27.3076  4.79991 
 48      92          95        225    67.7      224      11.36     5.47   0.98969  28.7551  3.13964 
 49      58          91        179    54.0      152      25.51    67.90   0.94444  30.5149  5.61538 
 50      86         116        235    32.2      108      43.64    37.59   0.84138  47.0861  5.26681 
 51      80          94        181    40.1      193      21.96    28.21   0.87353  31.7801  4.76946 
 52      80          89        165    37.8       99      28.38    37.03   0.89965  31.5983  4.98685 
 53      83          98        152    46.1       15      36.22    59.27   0.97248  35.8169  5.55356 
 54       .         107        153    56.0       84      28.65    30.67   0.93860  27.3859  4.98260 
 55      72         176        267    59.5      203      37.63    89.34   0.82935  30.5871  6.54942 
 56      80         111        179    42.5      177      36.49    32.20   0.97321  31.9413  5.06798 
 57      82          99        160    39.9      105      25.96    30.18   1.08527  41.4319  4.88878 
 58      72          90        267    54.2      201      40.64    28.36   0.96124  33.7078  4.73127 
 59      70         105        230    47.7       77      37.13    27.90   0.93089  34.4840  4.86907 
 60      98         110        262    71.1      117      31.27    63.47   0.88393  30.0580  5.73753 
 61      70          71        192    53.4       94      14.57    25.51   0.91000  24.9396  4.38824 
 62     100         111        175    57.7       53      19.01    22.93   0.91379  30.8374  4.72846 
 63      72         178        212    45.7      286      29.73    79.14   0.94444  30.5149  6.43949 
95
64      72          97        151    27.1       45      22.97    48.81   0.86087  29.8184  5.34913 
 65      83         123        198    71.4      146      44.45   115.69   0.96183  36.6321  6.44958 
 66       .         152        273    87.9      151      32.97    27.31   0.93913  28.0966  5.21762 
 67      94          93        202    47.9      148      29.52    15.19   0.83465  38.8356  4.13972 
 68      72          97        224    38.0      147       4.20     8.18   0.90217  18.2041  3.56289 
 69      68         262        150    35.0      154      23.09    16.69   0.96296  38.0114  5.26964 
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Participant                                        Tricep                       percbod 
Obs      ID       Ethnicity  Age  Height  Weight  MAMC    SF     Hip   Waist   FFM     FAT    systolic 
 
70     P79           3       32   62.0    185.5  31.5   31.70  121.0  111.0  102.5    44.8      100 
 71     P8            3       41   62.5    187.0  33.0   24.00  116.0   99.0  128.0    31.6      130 
 72     P84           3       45   67.5    203.0  24.5   25.00  119.5  103.0  119.0    41.4      120 
 73     P85           3       29   66.0    143.0  30.0   28.00   96.0   77.5   94.5    34.0       97 
 74     P87           3       34   67.5    181.5  30.0   24.70  115.0  103.0  107.5    40.9      140 
 75     P9            3       43   61.5    195.5  36.5   27.00  119.0  106.0  106.0    45.9      130 
 76     P90           3       30   67.5    180.0  30.0   27.70  113.0  101.0  104.0    42.3      112 
 77     P91           3       37   65.5    156.0  29.0   24.30  113.0  117.0   94.5    39.5      110 
 78     P95           3       38   63.5    300.5  46.0   43.00  150.0  145.0  136.0    54.7      130 
 79     P96           3       29   65.0    187.0  38.0   38.30  115.0  103.0  110.0    41.3      132 
 80     P98           3       29   64.5    136.0  28.0   27.00  103.0   97.0   89.0    34.4      126 
 81     P99           3       30   64.0    234.5  34.0   35.00  139.5  109.5  121.0    48.5      130 
 
ser 
Obs  diastolic  serglucose  stotchol   HDL  sertriglyc  leptin  insulin  waisthip    bmi     homair 
 
70      78         105        139    34.5      202      24.47    15.57   0.91736  33.9971  4.28579 
 71      82         108        243    35.7      476      34.15    73.19   0.85345  33.7258  5.86167 
 72      70         178        212    45.7      286      29.73      .     0.86192  31.3884   . 
 73      82         104        177    60.0       47      34.72    23.31   0.80729  23.1275  4.67976 
 74      84          85        176    48.6       55      34.21    26.99   0.89565  28.0640  4.62460 
 75      78          63         70    17.2       25      28.48    46.40   0.89076  36.4148  4.86692 
 76      74         103        182    40.1      237       6.02   142.21   0.89381  27.8321  6.47852 
 77      60          93        239    80.7      360      17.97    41.21   1.03540  25.6167  5.13777 
 78      84         123        160    48.5      154      60.32   171.18   0.96667  52.5023  6.84138 
 79      82         103        158    54.6      118      29.38    26.77   0.89565  31.1814  4.80850 
 80      84          98        209    69.0       80      14.23     8.89   0.94175  23.0303  3.65638 
 81      88         114        263    20.5      304      52.30    52.80   0.78495  40.3333  5.58919 
 
Differences between ethnic groups
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The GLM Procedure 
 
Class Level Information 
 
Class          Levels    Values 
 
Ethnicity           2    1 3 
 
Smoke               2    1 2 
 
bp                  2    1 2 
 
Data for Analysis of Height Weight bmi 
 Waist serglucose totchol HDL triglyc 
 
Number of Observations Read          81 
 Number of Observations Used          80 
 
Data for Analysis of MAMC 
 
Number of Observations Read          81 
 Number of Observations Used          77 
 
Data for Analysis of TricepSF 
 
Number of Observations Read          81 
 Number of Observations Used          78 
96
Data for Analysis of Wrist 
 
Number of Observations Read          81 
 Number of Observations Used          77 
 
Data for Analysis of Hip waisthip 
 
Number of Observations Read          81 
 Number of Observations Used          79 
 
Data for Analysis of FFM percbFAT 
 
Number of Observations Read          81 
 Number of Observations Used          79 
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The GLM Procedure 
 
Data for Analysis of diastolic systolic 
 
Number of Observations Read          81 
 Number of Observations Used          72 
 
Data for Analysis of leptin 
 
Number of Observations Read          81 
 Number of Observations Used          79 
 
Data for Analysis of insulin homair 
 
Number of Observations Read          81 
 Number of Observations Used          78 
 
NOTE: Variables in each group are consistent with respect to the presence or absence of missing 
 values. 
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The GLM Procedure 
 
Dependent Variable: Height 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        1       0.2684256       0.2684256       0.07    0.7960 
 
Error                       78     311.1534494       3.9891468 
 
Corrected Total             79     311.4218750 
 
R-Square     Coeff Var      Root MSE    Height Mean 
 
0.000862      3.083122      1.997285       64.78125 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      0.26842561      0.26842561       0.07    0.7960 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      0.26842561      0.26842561       0.07    0.7960 
97
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The GLM Procedure 
 
Dependent Variable: Weight 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        1       3421.5459       3421.5459       1.61    0.2083 
 
Error                       78     165796.0509       2125.5904 
 
Corrected Total             79     169217.5969 
 
R-Square     Coeff Var      Root MSE    Weight Mean 
 
0.020220      23.16281      46.10413       199.0438 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     3421.545940     3421.545940       1.61    0.2083 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     3421.545940     3421.545940       1.61    0.2083 
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The GLM Procedure 
 
Dependent Variable: bmi 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        1       90.963982       90.963982       1.70    0.1967 
 
Error                       78     4185.445240       53.659554 
 
Corrected Total             79     4276.409222 
 
R-Square     Coeff Var      Root MSE      bmi Mean 
 
0.021271      21.95779      7.325268      33.36069 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     90.96398197     90.96398197       1.70    0.1967 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     90.96398197     90.96398197       1.70    0.1967 
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The GLM Procedure 
 
Dependent Variable: Waist 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        1       122.84008       122.84008       0.40    0.5301 
 
Error                       78     24089.01380       308.83351 
 
Corrected Total             79     24211.85388 
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R-Square     Coeff Var      Root MSE    Waist Mean 
 
0.005074      16.38131      17.57366      107.2788 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     122.8400775     122.8400775       0.40    0.5301 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     122.8400775     122.8400775       0.40    0.5301 
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The GLM Procedure 
 
Dependent Variable: serglucose 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        1      3272.91348      3272.91348       4.27    0.0421 
 
Error                       78     59807.88652       766.76778 
 
Corrected Total             79     63080.80000 
 
R-Square     Coeff Var      Root MSE    serglucose Mean 
 
0.051884      26.04946      27.69057           106.3000 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     3272.913475     3272.913475       4.27    0.0421 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     3272.913475     3272.913475       4.27    0.0421 
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The GLM Procedure 
 
Dependent Variable: totchol 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        1          2.2383          2.2383       0.00    0.9706 
 
Error                       78     127392.7492       1633.2404 
 
Corrected Total             79     127394.9875 
 
R-Square     Coeff Var      Root MSE    totchol Mean 
 
0.000018      20.72613      40.41337        194.9875 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      2.23830593      2.23830593       0.00    0.9706 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      2.23830593      2.23830593       0.00    0.9706 
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The GLM Procedure 
 
Dependent Variable: HDL 
99
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        1       657.10571       657.10571       2.64    0.1086 
 
Error                       78     19450.80629       249.36931 
 
Corrected Total             79     20107.91200 
 
R-Square     Coeff Var      Root MSE      HDL Mean 
 
0.032679      31.89544      15.79143      49.51000 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     657.1057073     657.1057073       2.64    0.1086 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     657.1057073     657.1057073       2.64    0.1086 
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The GLM Procedure 
 
Dependent Variable: triglyc 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        1      48383.7873      48383.7873       7.56    0.0074 
 
Error                       78     498881.7627       6395.9200 
 
Corrected Total             79     547265.5500 
 
R-Square     Coeff Var      Root MSE    triglyc Mean 
 
0.088410      64.01801      79.97450        124.9250 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     48383.78727     48383.78727       7.56    0.0074 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     48383.78727     48383.78727       7.56    0.0074 
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The GLM Procedure 
 
Dependent Variable: MAMC 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        1      294.869292      294.869292       9.07    0.0035 
 
Error                       75     2437.137721       32.495170 
 
Corrected Total             76     2732.007013 
 
R-Square     Coeff Var      Root MSE     MAMC Mean 
 
0.107931      16.42167      5.700453      34.71299 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     294.8692921     294.8692921       9.07    0.0035 
 
100
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     294.8692921     294.8692921       9.07    0.0035 
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The GLM Procedure 
 
Dependent Variable: TricepSF 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        1      353.585299      353.585299       4.68    0.0336 
 
Error                       76     5736.867169       75.485094 
 
Corrected Total             77     6090.452468 
 
R-Square     Coeff Var      Root MSE    TricepSF Mean 
 
0.058056      25.59169      8.688216         33.94936 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     353.5852991     353.5852991       4.68    0.0336 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     353.5852991     353.5852991       4.68    0.0336 
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The GLM Procedure 
 
Dependent Variable: Wrist 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        1      3.39228797      3.39228797       2.76    0.1009 
 
Error                       75     92.22946528      1.22972620 
 
Corrected Total             76     95.62175325 
 
R-Square     Coeff Var      Root MSE    Wrist Mean 
 
0.035476      6.832923      1.108930      16.22922 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      3.39228797      3.39228797       2.76    0.1009 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      3.39228797      3.39228797       2.76    0.1009 
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The GLM Procedure 
 
Dependent Variable: Hip 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        1       131.77567       131.77567       0.54    0.4634 
 
Error                       77     18685.65522       242.67085 
 
Corrected Total             78     18817.43089 
 
R-Square     Coeff Var      Root MSE      Hip Mean 
101
0.007003      13.17574      15.57790      118.2316 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     131.7756667     131.7756667       0.54    0.4634 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     131.7756667     131.7756667       0.54    0.4634 
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The GLM Procedure 
 
Dependent Variable: waisthip 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        1      0.00199002      0.00199002       0.39    0.5361 
 
Error                       77      0.39660831      0.00515076 
 
Corrected Total             78      0.39859833 
 
R-Square     Coeff Var      Root MSE    waisthip Mean 
 
0.004993      7.950381      0.071769         0.902709 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      0.00199002      0.00199002       0.39    0.5361 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      0.00199002      0.00199002       0.39    0.5361 
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The GLM Procedure 
 
Dependent Variable: FFM 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        1        99.22325        99.22325       0.53    0.4683 
 
Error                       77     14380.22612       186.75618 
 
Corrected Total             78     14479.44937 
 
R-Square     Coeff Var      Root MSE      FFM Mean 
 
0.006853      12.36448      13.66588      110.5253 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     99.22324719     99.22324719       0.53    0.4683 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     99.22324719     99.22324719       0.53    0.4683 
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The GLM Procedure 
 
Dependent Variable: percbFAT 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
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Model                        1       63.006800       63.006800       1.10    0.2970 
 
Error                       77     4399.601555       57.137683 
 
Corrected Total             78     4462.608354 
 
R-Square     Coeff Var      Root MSE    percbFAT Mean 
 
0.014119      17.63606      7.558947         42.86076 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     63.00679975     63.00679975       1.10    0.2970 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     63.00679975     63.00679975       1.10    0.2970 
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The GLM Procedure 
 
Dependent Variable: diastolic 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        1       322.91558       322.91558       1.99    0.1627 
 
Error                       70     11354.58442       162.20835 
 
Corrected Total             71     11677.50000 
 
R-Square     Coeff Var      Root MSE    diastolic Mean 
 
0.027653      10.11471      12.73610          125.9167 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     322.9155844     322.9155844       1.99    0.1627 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     322.9155844     322.9155844       1.99    0.1627 
 
The SAS System         21:43 Thursday, July 6, 2006 200 
 
The GLM Procedure 
 
Dependent Variable: systolic 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        1      116.307540      116.307540       1.44    0.2348 
 
Error                       70     5668.678571       80.981122 
 
Corrected Total             71     5784.986111 
 
R-Square     Coeff Var      Root MSE    systolic Mean 
 
0.020105      11.00602      8.998951         81.76389 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     116.3075397     116.3075397       1.44    0.2348 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     116.3075397     116.3075397       1.44    0.2348 
103
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The GLM Procedure 
 
Dependent Variable: leptin 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        1      1125.07438      1125.07438       5.29    0.0241 
 
Error                       77     16373.99149       212.64924 
 
Corrected Total             78     17499.06587 
 
R-Square     Coeff Var      Root MSE    leptin Mean 
 
0.064293      46.95997      14.58250       31.05304 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     1125.074383     1125.074383       5.29    0.0241 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     1125.074383     1125.074383       5.29    0.0241 
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The GLM Procedure 
 
Dependent Variable: insulin 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        1       3370.3652       3370.3652       1.59    0.2106 
 
Error                       76     160684.1380       2114.2650 
 
Corrected Total             77     164054.5031 
 
R-Square     Coeff Var      Root MSE    insulin Mean 
 
0.020544      96.97593      45.98114        47.41500 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     3370.365163     3370.365163       1.59    0.2106 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     3370.365163     3370.365163       1.59    0.2106 
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The GLM Procedure 
 
Dependent Variable: homair 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        1      0.02325180      0.02325180       0.03    0.8705 
 
Error                       76     66.03676713      0.86890483 
 
Corrected Total             77     66.06001893 
 
R-Square     Coeff Var      Root MSE    homair Mean 
 
0.000352      228.2188      0.932151       0.408446 
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Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      0.02325180      0.02325180       0.03    0.8705 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      0.02325180      0.02325180       0.03    0.8705 
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The GLM Procedure 
 
Class Level Information 
 
Class          Levels    Values 
 
Ethnicity           2    1 3 
 
Smoke               2    1 2 
 
bp                  2    1 2 
 
Data for Analysis of Height Weight bmi 
 Waist serglucose totchol HDL triglyc 
 
Number of Observations Read          81 
 Number of Observations Used          80 
 
Data for Analysis of MAMC 
 
Number of Observations Read          81 
 Number of Observations Used          77 
 
Data for Analysis of TricepSF 
 
Number of Observations Read          81 
 Number of Observations Used          78 
 
Data for Analysis of Wrist 
 
Number of Observations Read          81 
 Number of Observations Used          77 
 
Data for Analysis of Hip waisthip 
 
Number of Observations Read          81 
 Number of Observations Used          79 
 
Data for Analysis of FFM percbFAT 
 
Number of Observations Read          81 
 Number of Observations Used          79 
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The GLM Procedure 
 
Data for Analysis of diastolic systolic 
 
Number of Observations Read          81 
 Number of Observations Used          72 
 
Data for Analysis of leptin 
 
Number of Observations Read          81 
 Number of Observations Used          79 
 
Data for Analysis of insulin homair 
 
105
Number of Observations Read          81 
 Number of Observations Used          78 
 
NOTE: Variables in each group are consistent with respect to the presence or absence of missing 
 values. 
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The GLM Procedure 
 
Dependent Variable: Height 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        3       3.4864130       1.1621377       0.29    0.8348 
 
Error                       76     307.9354620       4.0517824 
 
Corrected Total             79     311.4218750 
 
R-Square     Coeff Var      Root MSE    Height Mean 
 
0.011195      3.107232      2.012904       64.78125 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      0.26842561      0.26842561       0.07    0.7976 
 bp                           1      0.44402197      0.44402197       0.11    0.7415 
 Ethnicity*bp                 1      2.77396546      2.77396546       0.68    0.4106 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      0.31938482      0.31938482       0.08    0.7797 
 bp                           1      0.89848159      0.89848159       0.22    0.6391 
 Ethnicity*bp                 1      2.77396546      2.77396546       0.68    0.4106 
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The GLM Procedure 
 
Dependent Variable: Weight 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        3      27960.2856       9320.0952       5.01    0.0032 
 
Error                       76     141257.3113       1858.6488 
 
Corrected Total             79     169217.5969 
 
R-Square     Coeff Var      Root MSE    Weight Mean 
 
0.165233      21.65958      43.11205       199.0438 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      3421.54594      3421.54594       1.84    0.1789 
 bp                           1     23445.12977     23445.12977      12.61    0.0007 
 Ethnicity*bp                 1      1093.60985      1093.60985       0.59    0.4454 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      3239.13031      3239.13031       1.74    0.1908 
 bp                           1     24505.93082     24505.93082      13.18    0.0005 
 Ethnicity*bp                 1      1093.60985      1093.60985       0.59    0.4454 
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The GLM Procedure 
 
Dependent Variable: bmi 
 
106
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        3      751.716821      250.572274       5.40    0.0020 
 
Error                       76     3524.692401       46.377532 
 
Corrected Total             79     4276.409222 
 
R-Square     Coeff Var      Root MSE      bmi Mean 
 
0.175782      20.41356      6.810105      33.36069 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      90.9639820      90.9639820       1.96    0.1654 
 bp                           1     641.8896467     641.8896467      13.84    0.0004 
 Ethnicity*bp                 1      18.8631920      18.8631920       0.41    0.5256 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      86.6020038      86.6020038       1.87    0.1758 
 bp                           1     660.7261198     660.7261198      14.25    0.0003 
 Ethnicity*bp                 1      18.8631920      18.8631920       0.41    0.5256 
 
The SAS System         21:43 Thursday, July 6, 2006 209 
 
The GLM Procedure 
 
Dependent Variable: Waist 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        3      2256.90215       752.30072       2.60    0.0579 
 
Error                       76     21954.95172       288.88094 
 
Corrected Total             79     24211.85388 
 
R-Square     Coeff Var      Root MSE    Waist Mean 
 
0.093215      15.84330      16.99650      107.2788 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      122.840077      122.840077       0.43    0.5163 
 bp                           1     1968.425080     1968.425080       6.81    0.0109 
 Ethnicity*bp                 1      165.636995      165.636995       0.57    0.4513 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      111.092995      111.092995       0.38    0.5370 
 bp                           1     2110.084892     2110.084892       7.30    0.0085 
 Ethnicity*bp                 1      165.636995      165.636995       0.57    0.4513 
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The GLM Procedure 
 
Dependent Variable: serglucose 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        3      3614.07014      1204.69005       1.54    0.2111 
 
Error                       76     59466.72986       782.45697 
 
Corrected Total             79     63080.80000 
 
R-Square     Coeff Var      Root MSE    serglucose Mean 
 
0.057293      26.31461      27.97243           106.3000 
107
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     3272.913475     3272.913475       4.18    0.0443 
 bp                           1      106.620428      106.620428       0.14    0.7131 
 Ethnicity*bp                 1      234.536237      234.536237       0.30    0.5856 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     3311.978818     3311.978818       4.23    0.0431 
 bp                           1       55.987076       55.987076       0.07    0.7898 
 Ethnicity*bp                 1      234.536237      234.536237       0.30    0.5856 
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The GLM Procedure 
 
Dependent Variable: totchol 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        3       8245.4216       2748.4739       1.75    0.1633 
 
Error                       76     119149.5659       1567.7574 
 
Corrected Total             79     127394.9875 
 
R-Square     Coeff Var      Root MSE    totchol Mean 
 
0.064723      20.30639      39.59492        194.9875 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1        2.238306        2.238306       0.00    0.9700 
 bp                           1     3768.783259     3768.783259       2.40    0.1252 
 Ethnicity*bp                 1     4474.400025     4474.400025       2.85    0.0952 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1        0.308283        0.308283       0.00    0.9888 
 bp                           1     5207.299767     5207.299767       3.32    0.0723 
 Ethnicity*bp                 1     4474.400025     4474.400025       2.85    0.0952 
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The GLM Procedure 
 
Dependent Variable: HDL 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        3      1448.92553       482.97518       1.97    0.1260 
 
Error                       76     18658.98647       245.51298 
 
Corrected Total             79     20107.91200 
 
R-Square     Coeff Var      Root MSE      HDL Mean 
 
0.072057      31.64786      15.66885      49.51000 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     657.1057073     657.1057073       2.68    0.1060 
 bp                           1      76.9577117      76.9577117       0.31    0.5772 
 Ethnicity*bp                 1     714.8621088     714.8621088       2.91    0.0920 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     695.6103927     695.6103927       2.83    0.0964 
 bp                           1     177.4709862     177.4709862       0.72    0.3979 
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Ethnicity*bp                 1     714.8621088     714.8621088       2.91    0.0920 
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The GLM Procedure 
 
Dependent Variable: triglyc 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        3      48542.1449      16180.7150       2.47    0.0686 
 
Error                       76     498723.4051       6562.1501 
 
Corrected Total             79     547265.5500 
 
R-Square     Coeff Var      Root MSE    triglyc Mean 
 
0.088699      64.84459      81.00710        124.9250 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     48383.78727     48383.78727       7.37    0.0082 
 bp                           1       138.18438       138.18438       0.02    0.8850 
 Ethnicity*bp                 1        20.17325        20.17325       0.00    0.9559 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     48378.18357     48378.18357       7.37    0.0082 
 bp                           1       116.34409       116.34409       0.02    0.8944 
 Ethnicity*bp                 1        20.17325        20.17325       0.00    0.9559 
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The GLM Procedure 
 
Dependent Variable: MAMC 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        3      828.748071      276.249357      10.60    <.0001 
 
Error                       73     1903.258942       26.072040 
 
Corrected Total             76     2732.007013 
 
R-Square     Coeff Var      Root MSE     MAMC Mean 
 
0.303348      14.70942      5.106079      34.71299 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     294.8692921     294.8692921      11.31    0.0012 
 bp                           1     508.5362492     508.5362492      19.51    <.0001 
 Ethnicity*bp                 1      25.3425300      25.3425300       0.97    0.3274 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     260.7694740     260.7694740      10.00    0.0023 
 bp                           1     533.6675850     533.6675850      20.47    <.0001 
 Ethnicity*bp                 1      25.3425300      25.3425300       0.97    0.3274 
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The GLM Procedure 
 
Dependent Variable: TricepSF 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        3      785.751821      261.917274       3.65    0.0163 
 
109
Error                       74     5304.700647       71.685144 
 
Corrected Total             77     6090.452468 
 
R-Square     Coeff Var      Root MSE    TricepSF Mean 
 
0.129014      24.93923      8.466708         33.94936 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     353.5852991     353.5852991       4.93    0.0294 
 bp                           1     425.5124183     425.5124183       5.94    0.0172 
 Ethnicity*bp                 1       6.6541040       6.6541040       0.09    0.7615 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     317.3667423     317.3667423       4.43    0.0388 
 bp                           1     428.9357847     428.9357847       5.98    0.0168 
 Ethnicity*bp                 1       6.6541040       6.6541040       0.09    0.7615 
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The GLM Procedure 
 
Dependent Variable: Wrist 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        3      7.26330787      2.42110262       2.00    0.1214 
 
Error                       73     88.35844538      1.21038966 
 
Corrected Total             76     95.62175325 
 
R-Square     Coeff Var      Root MSE    Wrist Mean 
 
0.075959      6.778989      1.100177      16.22922 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      3.39228797      3.39228797       2.80    0.0984 
 bp                           1      3.78561733      3.78561733       3.13    0.0812 
 Ethnicity*bp                 1      0.08540257      0.08540257       0.07    0.7913 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      3.32418097      3.32418097       2.75    0.1018 
 bp                           1      3.86942605      3.86942605       3.20    0.0779 
 Ethnicity*bp                 1      0.08540257      0.08540257       0.07    0.7913 
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The GLM Procedure 
 
Dependent Variable: Hip 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        3      1814.77037       604.92346       2.67    0.0537 
 
Error                       75     17002.66052       226.70214 
 
Corrected Total             78     18817.43089 
 
R-Square     Coeff Var      Root MSE      Hip Mean 
 
0.096441      12.73486      15.05663      118.2316 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      131.775667      131.775667       0.58    0.4482 
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bp                           1     1649.474409     1649.474409       7.28    0.0086 
 Ethnicity*bp                 1       33.520295       33.520295       0.15    0.7017 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      140.484454      140.484454       0.62    0.4336 
 bp                           1     1678.922342     1678.922342       7.41    0.0081 
 Ethnicity*bp                 1       33.520295       33.520295       0.15    0.7017 
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The GLM Procedure 
 
Dependent Variable: waisthip 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        3      0.00320769      0.00106923       0.20    0.8941 
 
Error                       75      0.39539064      0.00527188 
 
Corrected Total             78      0.39859833 
 
R-Square     Coeff Var      Root MSE    waisthip Mean 
 
0.008047      8.043313      0.072608         0.902709 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      0.00199002      0.00199002       0.38    0.5408 
 bp                           1      0.00089233      0.00089233       0.17    0.6819 
 Ethnicity*bp                 1      0.00032534      0.00032534       0.06    0.8045 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      0.00197571      0.00197571       0.37    0.5423 
 bp                           1      0.00107260      0.00107260       0.20    0.6532 
 Ethnicity*bp                 1      0.00032534      0.00032534       0.06    0.8045 
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The GLM Procedure 
 
Dependent Variable: FFM 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        3      1683.11615       561.03872       3.29    0.0252 
 
Error                       75     12796.33322       170.61778 
 
Corrected Total             78     14479.44937 
 
R-Square     Coeff Var      Root MSE      FFM Mean 
 
0.116242      11.81817      13.06207      110.5253 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1       99.223247       99.223247       0.58    0.4481 
 bp                           1     1530.826534     1530.826534       8.97    0.0037 
 Ethnicity*bp                 1       53.066364       53.066364       0.31    0.5787 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1       98.960271       98.960271       0.58    0.4487 
 bp                           1     1583.306075     1583.306075       9.28    0.0032 
 Ethnicity*bp                 1       53.066364       53.066364       0.31    0.5787 
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The GLM Procedure 
111
Dependent Variable: percbFAT 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        3      694.777976      231.592659       4.61    0.0051 
 
Error                       75     3767.830379       50.237738 
 
Corrected Total             78     4462.608354 
 
R-Square     Coeff Var      Root MSE    percbFAT Mean 
 
0.155689      16.53694      7.087859         42.86076 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      63.0067998      63.0067998       1.25    0.2663 
 bp                           1     624.0785616     624.0785616      12.42    0.0007 
 Ethnicity*bp                 1       7.6926143       7.6926143       0.15    0.6967 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      63.9270878      63.9270878       1.27    0.2629 
 bp                           1     629.9131487     629.9131487      12.54    0.0007 
 Ethnicity*bp                 1       7.6926143       7.6926143       0.15    0.6967 
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The GLM Procedure 
 
Dependent Variable: diastolic 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        3      8003.17326      2667.72442      49.37    <.0001 
 
Error                       68      3674.32674        54.03422 
 
Corrected Total             71     11677.50000 
 
R-Square     Coeff Var      Root MSE    diastolic Mean 
 
0.685350      5.837827      7.350797          125.9167 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      322.915584      322.915584       5.98    0.0171 
 bp                           1     7651.108137     7651.108137     141.60    <.0001 
 Ethnicity*bp                 1       29.149540       29.149540       0.54    0.4652 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      133.217475      133.217475       2.47    0.1210 
 bp                           1     7430.630803     7430.630803     137.52    <.0001 
 Ethnicity*bp                 1       29.149540       29.149540       0.54    0.4652 
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The GLM Procedure 
 
Dependent Variable: systolic 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        3     2256.265211      752.088404      14.49    <.0001 
 
Error                       68     3528.720900       51.892954 
 
Corrected Total             71     5784.986111 
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R-Square     Coeff Var      Root MSE    systolic Mean 
 
0.390021      8.810340      7.203676         81.76389 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      116.307540      116.307540       2.24    0.1390 
 bp                           1     2051.032227     2051.032227      39.52    <.0001 
 Ethnicity*bp                 1       88.925445       88.925445       1.71    0.1949 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1       89.868771       89.868771       1.73    0.1926 
 bp                           1     1738.084758     1738.084758      33.49    <.0001 
 Ethnicity*bp                 1       88.925445       88.925445       1.71    0.1949 
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The GLM Procedure 
 
Dependent Variable: leptin 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        3      4772.74901      1590.91634       9.38    <.0001 
 
Error                       75     12726.31686       169.68422 
 
Corrected Total             78     17499.06587 
 
R-Square     Coeff Var      Root MSE    leptin Mean 
 
0.272743      41.94852      13.02629       31.05304 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     1125.074383     1125.074383       6.63    0.0120 
 bp                           1     3148.350094     3148.350094      18.55    <.0001 
 Ethnicity*bp                 1      499.324529      499.324529       2.94    0.0904 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     1151.414624     1151.414624       6.79    0.0111 
 bp                           1     3520.020025     3520.020025      20.74    <.0001 
 Ethnicity*bp                 1      499.324529      499.324529       2.94    0.0904 
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The GLM Procedure 
 
Dependent Variable: insulin 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        3       5370.8306       1790.2769       0.83    0.4790 
 
Error                       74     158683.6726       2144.3740 
 
Corrected Total             77     164054.5031 
 
R-Square     Coeff Var      Root MSE    insulin Mean 
 
0.032738      97.66400      46.30739        47.41500 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1     3370.365163     3370.365163       1.57    0.2139 
 bp                           1     1927.464451     1927.464451       0.90    0.3462 
 Ethnicity*bp                 1       73.000975       73.000975       0.03    0.8541 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
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Ethnicity                    1     3366.561187     3366.561187       1.57    0.2142 
 bp                           1     1733.903346     1733.903346       0.81    0.3715 
 Ethnicity*bp                 1       73.000975       73.000975       0.03    0.8541 
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The GLM Procedure 
 
Dependent Variable: homair 
 
Sum of 
 Source                      DF         Squares     Mean Square    F Value    Pr > F 
 
Model                        3      2.33798494      0.77932831       0.91    0.4429 
 
Error                       74     63.72203399      0.86110857 
 
Corrected Total             77     66.06001893 
 
R-Square     Coeff Var      Root MSE    homair Mean 
 
0.035392      227.1927      0.927959       0.408446 
 
Source                      DF       Type I SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      0.02325180      0.02325180       0.03    0.8699 
 bp                           1      2.01050390      2.01050390       2.33    0.1308 
 Ethnicity*bp                 1      0.30422924      0.30422924       0.35    0.5541 
 
Source                      DF     Type III SS     Mean Square    F Value    Pr > F 
 
Ethnicity                    1      0.03829401      0.03829401       0.04    0.8336 
 bp                           1      2.23257755      2.23257755       2.59    0.1116 
 Ethnicity*bp                 1      0.30422924      0.30422924       0.35    0.5541 
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The MEANS Procedure 
 
Variable       N            Mean         Std Dev       Std Error         Minimum         Maximum 
 ???????????????????????????????????????????????????????????????????????????????????????????????? 
Ethnicity     81       2.1851852       0.9888265       0.1098696       1.0000000       3.0000000 
 Age           81      34.2345679       5.7971364       0.6441263      22.0000000      45.0000000 
 Height        81      64.7839506       1.9731610       0.2192401      61.0000000      71.5000000 
 Weight        81     198.6666667      46.1165643       5.1240627     107.5000000     346.5000000 
 MAMC          78      34.6910256       5.9597173       0.6748051      24.5000000      59.0000000 
 TricepSF      79      33.9500000       8.8364448       0.9941777      13.7000000      54.3000000 
 Hip           80     118.1912500      15.4378066       1.7259992      83.5000000     150.0000000 
 Waist         81     107.2876543      17.3969709       1.9329968      69.5000000     150.0000000 
 FFM           80     110.4187500      13.5717605       1.5173689      83.5000000     145.5000000 
 percbodFAT    80      42.8187500       7.5252839       0.8413523      20.3000000      58.0000000 
 systolic      72     125.9166667      12.8246571       1.5114003      97.0000000     160.0000000 
 diastolic     72      81.7638889       9.0265540       1.0637896      58.0000000     100.0000000 
 serglucose    81     106.8641975      28.5358341       3.1706482      60.0000000     262.0000000 
 stotchol      81     195.9506173      40.8359221       4.5373247      70.0000000     274.0000000 
 serHDL        81      49.9839506      16.4177911       1.8241990      17.2000000      87.9000000 
 sertriglyc    81     125.2469136      82.7599738       9.1955526       1.0000000     476.0000000 
 leptin        80      31.0770000      14.8846598       1.6641556       4.2000000      79.6500000 
 insulin       79      47.1605063      45.9170933       5.1660766       4.0600000     269.5800000 
 waisthip      80       0.9031639       0.0711486       0.0079547       0.6200000       1.0852713 
 bmi           81      33.2956970       7.3346587       0.8149621      18.2041344      52.5022630 
 homair        79       5.0161985       0.9205705       0.1035723       2.6314731       7.0885201 
 ???????????????????????????????????????????????????????????????????????????????????????????????? 
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The TTEST Procedure 
 
Statistics 
 
Lower CL          Upper CL  Lower CL           Upper CL 
 Variable    Ethnicity         N      Mean    Mean      Mean   Std Dev  Std Dev   Std Dev  Std Err 
 
Age                    1     33    32.467  34.485    36.503    4.5763   5.6906    7.5269   0.9906 
 Age                    3     48    32.343  34.063    35.782    4.9307   5.9229    7.4189   0.8549 
 Age         Diff (1-2)             -2.202  0.4223    3.0464    5.0455   5.8299    6.9054   1.3183 
 Height                 1     33    63.858  64.712    65.566    1.9363   2.4078    3.1847   0.4191 
 Height                 3     48    64.359  64.833    65.308    1.3612   1.6352    2.0482    0.236 
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Height      Diff (1-2)             -1.015  -0.121    0.7721    1.7177   1.9847    2.3508   0.4488 
 Weight                 1     33    187.44  206.85    226.26    44.017   54.735    72.398   9.5282 
 Weight                 3     48    181.79  193.04    204.29    32.251   38.741    48.526   5.5918 
 Weight      Diff (1-2)             -6.851  13.807    34.465    39.721   45.896    54.363   10.379 
 bmi                    1     33    31.705  34.633    37.561    6.6408   8.2577    10.922   1.4375 
 bmi                    3     48    30.472  32.376    34.281    5.4603   6.5592    8.2159   0.9467 
 bmi         Diff (1-2)             -1.026  2.2571    5.5407    6.3135    7.295    8.6407   1.6496 
 MAMC                   1     31    34.473  37.097    39.721    5.7165   7.1536     9.562   1.2848 
 MAMC                   3     47    31.804  33.104    34.404    3.6796    4.428    5.5615   0.6459 
 MAMC        Diff (1-2)             1.3829  3.9925    6.6021    4.8881   5.6628    6.7317   1.3102 
 TricepSF               1     31    32.993  36.571    40.149    7.7956   9.7553     13.04   1.7521 
 TricepSF               3     48    29.982  32.257    34.532    6.5222   7.8347    9.8136   1.1308 
 TricepSF    Diff (1-2)             0.3523  4.3137    8.2751    7.4594   8.6339    10.251   1.9894 
 Hip                    1     32    113.14   119.8    126.45      14.8    18.46    24.543   3.2634 
 Hip                    3     48     113.3  117.12    120.94    10.946   13.149     16.47   1.8979 
 Hip         Diff (1-2)             -4.357   2.676    9.7092    13.385    15.48    18.357   3.5327 
 Waist                  1     33    101.09  108.76    116.42    17.388   21.622    28.599   3.7639 
 Waist                  3     48    102.23  106.28    110.32    11.604   13.939     17.46   2.0119 
 Waist       Diff (1-2)              -5.38  2.4805    10.341    15.114   17.463    20.685    3.949 
 FFM                    1     33    106.64  111.85    117.06    11.812   14.689    19.429    2.557 
 FFM                    3     47    105.66  109.41    113.17    10.633   12.796    16.072   1.8665 
 FFM         Diff (1-2)             -3.718  2.4336    8.5848    11.764   13.604    16.133   3.0897 
 percbodFAT             1     33    40.877  43.915    46.953    6.8898   8.5674    11.332   1.4914 
 percbodFAT             3     47    40.085  42.049    44.013    5.5574   6.6878    8.3998   0.9755 
 percbodFAT  Diff (1-2)             -1.532  1.8662    5.2645    6.4992    7.516     8.913    1.707 
 systolic               1     28    123.22  128.57    133.93    10.916   13.807    18.793   2.6092 
 systolic               3     44    120.57  124.23    127.88    9.9273   12.015    15.224   1.8114 
 systolic    Diff (1-2)             -1.797  4.3442    10.485    10.931   12.736     15.26   3.0789 
 diastolic              1     28    80.147  83.357    86.567    6.5452   8.2786    11.268   1.5645 
 diastolic              3     44    77.885   80.75    83.615    7.7857   9.4232    11.939   1.4206 
 diastolic   Diff (1-2)             -1.732  2.6071     6.946    7.7237    8.999    10.783   2.1755 
 serglucose             1     33    92.471  98.667    104.86    14.051   17.473    23.111   3.0416 
 serglucose             3     48    102.88   112.5    122.12    27.592   33.144    41.516    4.784 
 serglucose  Diff (1-2)             -26.38  -13.83    -1.285    24.128   27.879    33.022   6.3043 
 stotchol               1     33    182.18  194.79     207.4    28.595   35.557    47.031   6.1897 
 stotchol               3     48    183.84  196.75    209.66    37.005   44.452     55.68   6.4162 
 stotchol    Diff (1-2)             -20.45  -1.962    16.529    35.555   41.082     48.66     9.29 
 serHDL                 1     33    47.048   52.93    58.812     13.34   16.589    21.942   2.8877 
 serHDL                 3     48    43.266  47.958    52.651    13.453    16.16    20.242   2.3325 
 serHDL      Diff (1-2)             -2.381   4.972    12.325    14.137   16.335    19.349   3.6939 
 sertriglyc             1     33    75.472  95.576    115.68    45.596   56.698    74.994   9.8698 
 sertriglyc             3     48    118.99  145.65     172.3    76.417   91.796    114.98    13.25 
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Statistics 
 
Lower CL          Upper CL  Lower CL           Upper CL 
 Variable    Ethnicity         N      Mean    Mean      Mean   Std Dev  Std Dev   Std Dev  Std Err 
 
sertriglyc  Diff (1-2)             -85.84  -50.07     -14.3    68.777   79.469    94.129   17.971 
 leptin                 1     32    29.392  35.627    41.861    13.863   17.292    22.989   3.0568 
 leptin                 3     48    24.468  28.044     31.62    10.253   12.316    15.427   1.7777 
 leptin      Diff (1-2)             0.9947  7.5826     14.17    12.538     14.5    17.195   3.3091 
 insulin                1     32    34.064  55.296    76.528    47.213    58.89    78.293    10.41 
 insulin                3     47    31.619  41.621    51.624    28.308   34.066    42.787   4.9691 
 insulin     Diff (1-2)             -7.186  13.675    34.536    39.493   45.711    54.273   10.476 
 homair                 1     32    4.5989  4.9929    5.3869    0.8761   1.0928    1.4529   0.1932 
 homair                 3     47    4.7987  5.0321    5.2654    0.6604   0.7947    0.9981   0.1159 
 homair      Diff (1-2)             -0.462  -0.039    0.3836    0.8003   0.9263    1.0998   0.2123 
 waisthip               1     32    0.8664  0.8966    0.9269    0.0673    0.084    0.1116   0.0148 
 waisthip               3     48    0.8896  0.9075    0.9254    0.0514   0.0617    0.0773   0.0089 
 waisthip    Diff (1-2)             -0.043  -0.011    0.0215    0.0617   0.0714    0.0847   0.0163 
 
T-Tests 
 
Variable      Method           Variances      DF    t Value    Pr > |t| 
 
Age           Pooled           Equal          79       0.32      0.7495 
 Age           Satterthwaite    Unequal      70.7       0.32      0.7478 
 Height        Pooled           Equal          79      -0.27      0.7878 
 Height        Satterthwaite    Unequal        52      -0.25      0.8020 
 Weight        Pooled           Equal          79       1.33      0.1872 
 Weight        Satterthwaite    Unequal      53.5       1.25      0.2168 
 bmi           Pooled           Equal          79       1.37      0.1751 
 bmi           Satterthwaite    Unequal      58.3       1.31      0.1949 
 MAMC          Pooled           Equal          76       3.05      0.0032 
 MAMC          Satterthwaite    Unequal      45.2       2.78      0.0080 
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TricepSF      Pooled           Equal          77       2.17      0.0332 
 TricepSF      Satterthwaite    Unequal      54.2       2.07      0.0434 
 Hip           Pooled           Equal          78       0.76      0.4510 
 Hip           Satterthwaite    Unequal      51.6       0.71      0.4816 
 Waist         Pooled           Equal          79       0.63      0.5317 
 Waist         Satterthwaite    Unequal      50.1       0.58      0.5637 
 FFM           Pooled           Equal          78       0.79      0.4333 
 FFM           Satterthwaite    Unequal      62.8       0.77      0.4449 
 percbodFAT    Pooled           Equal          78       1.09      0.2776 
 percbodFAT    Satterthwaite    Unequal      57.9       1.05      0.2994 
 systolic      Pooled           Equal          70       1.41      0.1627 
 systolic      Satterthwaite    Unequal      51.7       1.37      0.1773 
 diastolic     Pooled           Equal          70       1.20      0.2348 
 diastolic     Satterthwaite    Unequal        63       1.23      0.2219 
 serglucose    Pooled           Equal          79      -2.19      0.0312 
 serglucose    Satterthwaite    Unequal      74.7      -2.44      0.0171 
 stotchol      Pooled           Equal          79      -0.21      0.8333 
 stotchol      Satterthwaite    Unequal      77.1      -0.22      0.8264 
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T-Tests 
 
Variable      Method           Variances      DF    t Value    Pr > |t| 
 
serHDL        Pooled           Equal          79       1.35      0.1822 
 serHDL        Satterthwaite    Unequal      67.7       1.34      0.1849 
 sertriglyc    Pooled           Equal          79      -2.79      0.0067 
 sertriglyc    Satterthwaite    Unequal      78.2      -3.03      0.0033 
 leptin        Pooled           Equal          78       2.29      0.0246 
 leptin        Satterthwaite    Unequal      51.6       2.14      0.0367 
 insulin       Pooled           Equal          77       1.31      0.1957 
 insulin       Satterthwaite    Unequal      45.2       1.19      0.2420 
 homair        Pooled           Equal          77      -0.18      0.8542 
 homair        Satterthwaite    Unequal      52.7      -0.17      0.8628 
 waisthip      Pooled           Equal          78      -0.67      0.5056 
 waisthip      Satterthwaite    Unequal      52.8      -0.63      0.5318 
 
Equality of Variances 
 
Variable      Method      Num DF    Den DF    F Value    Pr > F 
 
Age           Folded F        47        32       1.08    0.8227 
 Height        Folded F        32        47       2.17    0.0154 
 Weight        Folded F        32        47       2.00    0.0304 
 bmi           Folded F        32        47       1.58    0.1479 
 MAMC          Folded F        30        46       2.61    0.0033 
 TricepSF      Folded F        30        47       1.55    0.1742 
 Hip           Folded F        31        47       1.97    0.0347 
 Waist         Folded F        32        47       2.41    0.0061 
 FFM           Folded F        32        46       1.32    0.3859 
 percbodFAT    Folded F        32        46       1.64    0.1220 
 systolic      Folded F        27        43       1.32    0.4074 
 diastolic     Folded F        43        27       1.30    0.4804 
 serglucose    Folded F        47        32       3.60    0.0003 
 stotchol      Folded F        47        32       1.56    0.1854 
 serHDL        Folded F        32        47       1.05    0.8562 
 sertriglyc    Folded F        47        32       2.62    0.0051 
 leptin        Folded F        31        47       1.97    0.0347 
 insulin       Folded F        31        46       2.99    0.0008 
 homair        Folded F        31        46       1.89    0.0487 
 waisthip      Folded F        31        47       1.85    0.0555 
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The CORR Procedure 
 
20  Variables:    Age        Height     Weight     bmi        MAMC       TricepSF   Hip        Waist 
 FFM        percbodFAT systolic   diastolic  serglucose stotchol   serHDL 
 sertriglyc leptin     insulin    homair     waisthip 
 
Simple Statistics 
 
Variable             N          Mean       Std Dev           Sum       Minimum       Maximum 
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Age                 33      34.48485       5.69057          1138      26.00000      45.00000 
 Height              33      64.71212       2.40777          2136      61.00000      71.50000 
 Weight              33     206.84848      54.73508          6826     111.00000     346.50000 
 bmi                 33      34.63326       8.25771          1143      19.70257      48.98764 
 MAMC                31      37.09677       7.15358          1150      27.00000      59.00000 
 TricepSF            31      36.57097       9.75528          1134      17.50000      54.30000 
 Hip                 32     119.79688      18.46045          3834      83.50000     150.00000 
 Waist               33     108.75758      21.62179          3589      69.50000     150.00000 
 FFM                 33     111.84848      14.68869          3691      88.50000     145.50000 
 percbodFAT          33      43.91515       8.56742          1449      20.30000      58.00000 
 systolic            28     128.57143      13.80668          3600     100.00000     160.00000 
 diastolic           28      83.35714       8.27855          2334      60.00000     100.00000 
 serglucose          33      98.66667      17.47260          3256      60.00000     161.00000 
 stotchol            33     194.78788      35.55696          6428     105.00000     272.00000 
 serHDL              33      52.93030      16.58867          1747      18.80000      87.90000 
 sertriglyc          33      95.57576      56.69768          3154       1.00000     283.00000 
 leptin              32      35.62656      17.29197          1140       5.29000      79.65000 
 insulin             32      55.29625      58.89027          1769       4.06000     269.58000 
 homair              32       4.99292       1.09282     159.77330       2.63147       7.08852 
 waisthip            32       0.89663       0.08396      28.69203       0.62000       1.00952 
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Pearson Correlation Coefficients 
 Prob > |r| under H0: Rho=0 
 Number of Observations 
 
Age       Height       Weight          bmi         MAMC     TricepSF          Hip 
 
Age            1.00000     -0.09327     -0.07184     -0.03980     -0.11129     -0.05245     -0.02960 
 0.6057       0.6911       0.8259       0.5511       0.7793       0.8723 
 33           33           33           33           31           31           32 
 
Height        -0.09327      1.00000      0.48427      0.19187      0.34751      0.08950      0.23086 
 0.6057                    0.0043       0.2848       0.0554       0.6321       0.2036 
 33           33           33           33           31           31           32 
 
Weight        -0.07184      0.48427      1.00000      0.94824      0.82814      0.73537      0.90862 
 0.6911       0.0043                    <.0001       <.0001       <.0001       <.0001 
 33           33           33           33           31           31           32 
 
bmi           -0.03980      0.19187      0.94824      1.00000      0.81391      0.79026      0.89852 
 0.8259       0.2848       <.0001                    <.0001       <.0001       <.0001 
 33           33           33           33           31           31           32 
 
MAMC          -0.11129      0.34751      0.82814      0.81391      1.00000      0.72844      0.79604 
 0.5511       0.0554       <.0001       <.0001                    <.0001       <.0001 
 31           31           31           31           31           30           30 
 
TricepSF      -0.05245      0.08950      0.73537      0.79026      0.72844      1.00000      0.74395 
 0.7793       0.6321       <.0001       <.0001       <.0001                    <.0001 
 31           31           31           31           30           31           30 
 
Hip           -0.02960      0.23086      0.90862      0.89852      0.79604      0.74395      1.00000 
 0.8723       0.2036       <.0001       <.0001       <.0001       <.0001 
 32           32           32           32           30           30           32 
 
Waist          0.05356      0.30520      0.90930      0.91361      0.77253      0.78921      0.84493 
 0.7672       0.0841       <.0001       <.0001       <.0001       <.0001       <.0001 
 33           33           33           33           31           31           32 
 
FFM           -0.09275      0.57240      0.95608      0.87122      0.80821      0.64481      0.84530 
 0.6077       0.0005       <.0001       <.0001       <.0001       <.0001       <.0001 
 33           33           33           33           31           31           32 
 
percbodFAT    -0.03996      0.34562      0.91825      0.92166      0.71875      0.77942      0.87064 
 0.8253       0.0488       <.0001       <.0001       <.0001       <.0001       <.0001 
 33           33           33           33           31           31           32 
 
systolic      -0.11159      0.30797      0.34062      0.29205      0.50670      0.03598      0.29989 
 0.5718       0.1109       0.0761       0.1316       0.0059       0.8558       0.1286 
 28           28           28           28           28           28           27 
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Pearson Correlation Coefficients 
 Prob > |r| under H0: Rho=0 
 Number of Observations 
 
Age       Height       Weight          bmi         MAMC     TricepSF          Hip 
 
diastolic      0.09547      0.05000      0.34266      0.36337      0.34114      0.26995      0.27236 
 0.6289       0.8005       0.0743       0.0573       0.0756       0.1648       0.1693 
 28           28           28           28           28           28           27 
 
serglucose    -0.04044      0.34454      0.30543      0.23648      0.38411      0.22508      0.17197 
 0.8232       0.0496       0.0839       0.1852       0.0329       0.2235       0.3466 
 33           33           33           33           31           31           32 
 
stotchol       0.22416      0.01350     -0.03118     -0.03563     -0.16101     -0.10857     -0.00110 
 0.2098       0.9406       0.8632       0.8439       0.3869       0.5610       0.9952 
 33           33           33           33           31           31           32 
 
serHDL         0.12024     -0.11095     -0.16635     -0.14959     -0.21502     -0.24718     -0.03595 
 0.5051       0.5388       0.3548       0.4060       0.2454       0.1801       0.8451 
 33           33           33           33           31           31           32 
 
sertriglyc    -0.00990      0.12429     -0.01255     -0.03308     -0.13303     -0.16229     -0.00439 
 0.9564       0.4907       0.9447       0.8550       0.4756       0.3831       0.9810 
 33           33           33           33           31           31           32 
 
leptin        -0.32733      0.15270      0.77995      0.81641      0.75711      0.75984      0.72116 
 0.0674       0.4041       <.0001       <.0001       <.0001       <.0001       <.0001 
 32           32           32           32           30           30           31 
 
insulin       -0.15265      0.31044      0.31515      0.24279      0.15836      0.05477      0.17457 
 0.4042       0.0838       0.0789       0.1806       0.4033       0.7738       0.3476 
 32           32           32           32           30           30           31 
 
homair        -0.15701      0.33961      0.58533      0.54246      0.46242      0.45353      0.47185 
 0.3908       0.0572       0.0004       0.0013       0.0101       0.0118       0.0074 
 32           32           32           32           30           30           31 
 
waisthip       0.22637      0.05079      0.37361      0.37273      0.32481      0.51888      0.14120 
 0.2128       0.7825       0.0352       0.0356       0.0799       0.0033       0.4408 
 32           32           32           32           30           30           32 
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Pearson Correlation Coefficients 
 Prob > |r| under H0: Rho=0 
 Number of Observations 
 
percbod 
 Waist         FFM         FAT    systolic    diastolic    serglucose    stotchol 
 
Age            0.05356    -0.09275    -0.03996    -0.11159      0.09547      -0.04044     0.22416 
 0.7672      0.6077      0.8253      0.5718       0.6289        0.8232      0.2098 
 33          33          33          28           28            33          33 
 
Height         0.30520     0.57240     0.34562     0.30797      0.05000       0.34454     0.01350 
 0.0841      0.0005      0.0488      0.1109       0.8005        0.0496      0.9406 
 33          33          33          28           28            33          33 
 
Weight         0.90930     0.95608     0.91825     0.34062      0.34266       0.30543    -0.03118 
 <.0001      <.0001      <.0001      0.0761       0.0743        0.0839      0.8632 
 33          33          33          28           28            33          33 
 
bmi            0.91361     0.87122     0.92166     0.29205      0.36337       0.23648    -0.03563 
 <.0001      <.0001      <.0001      0.1316       0.0573        0.1852      0.8439 
 33          33          33          28           28            33          33 
 
MAMC           0.77253     0.80821     0.71875     0.50670      0.34114       0.38411    -0.16101 
 <.0001      <.0001      <.0001      0.0059       0.0756        0.0329      0.3869 
 31          31          31          28           28            31          31 
 
TricepSF       0.78921     0.64481     0.77942     0.03598      0.26995       0.22508    -0.10857 
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<.0001      <.0001      <.0001      0.8558       0.1648        0.2235      0.5610 
 31          31          31          28           28            31          31 
 
Hip            0.84493     0.84530     0.87064     0.29989      0.27236       0.17197    -0.00110 
 <.0001      <.0001      <.0001      0.1286       0.1693        0.3466      0.9952 
 32          32          32          27           27            32          32 
 
Waist          1.00000     0.81041     0.90817     0.17929      0.31965       0.23668    -0.06395 
 <.0001      <.0001      0.3613       0.0973        0.1848      0.7237 
 33          33          33          28           28            33          33 
 
FFM            0.81041     1.00000     0.81045     0.44967      0.28961       0.30554    -0.06032 
 <.0001                  <.0001      0.0164       0.1350        0.0838      0.7388 
 33          33          33          28           28            33          33 
 
percbodFAT     0.90817     0.81045     1.00000     0.16328      0.30251       0.30392    -0.01259 
 <.0001      <.0001                  0.4064       0.1177        0.0855      0.9446 
 33          33          33          28           28            33          33 
 
systolic       0.17929     0.44967     0.16328     1.00000      0.45860       0.21177    -0.31220 
 0.3613      0.0164      0.4064                   0.0141        0.2793      0.1058 
 28          28          28          28           28            28          28 
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Pearson Correlation Coefficients 
 Prob > |r| under H0: Rho=0 
 Number of Observations 
 
percbod 
 Waist         FFM         FAT    systolic    diastolic    serglucose    stotchol 
 
diastolic      0.31965     0.28961     0.30251     0.45860      1.00000       0.20723    -0.27689 
 0.0973      0.1350      0.1177      0.0141                     0.2900      0.1537 
 28          28          28          28           28            28          28 
 
serglucose     0.23668     0.30554     0.30392     0.21177      0.20723       1.00000     0.31340 
 0.1848      0.0838      0.0855      0.2793       0.2900                    0.0757 
 33          33          33          28           28            33          33 
 
stotchol      -0.06395    -0.06032    -0.01259    -0.31220     -0.27689       0.31340     1.00000 
 0.7237      0.7388      0.9446      0.1058       0.1537        0.0757 
 33          33          33          28           28            33          33 
 
serHDL        -0.25341    -0.15610    -0.19238    -0.14843     -0.15145       0.02622     0.65316 
 0.1547      0.3857      0.2835      0.4510       0.4417        0.8848      <.0001 
 33          33          33          28           28            33          33 
 
sertriglyc     0.04784    -0.03272     0.11287    -0.19319     -0.17169      -0.03194    -0.04765 
 0.7915      0.8565      0.5317      0.3246       0.3823        0.8599      0.7923 
 33          33          33          28           28            33          33 
 
leptin         0.74213     0.67253     0.77223     0.29269      0.23077       0.13328    -0.08609 
 <.0001      <.0001      <.0001      0.1385       0.2468        0.4671      0.6394 
 32          32          32          27           27            32          32 
 
insulin        0.27219     0.30263     0.27909    -0.04163     -0.18658       0.03614     0.08829 
 0.1318      0.0923      0.1219      0.8367       0.3514        0.8443      0.6309 
 32          32          32          27           27            32          32 
 
homair         0.49609     0.57875     0.57969     0.08624     -0.03101       0.29365     0.04024 
 0.0039      0.0005      0.0005      0.6689       0.8780        0.1028      0.8269 
 32          32          32          27           27            32          32 
 
waisthip       0.64313     0.23388     0.44275    -0.26418      0.07979       0.11834    -0.12812 
 <.0001      0.1976      0.0112      0.1830       0.6924        0.5189      0.4847 
 32          32          32          27           27            32          32 
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 Prob > |r| under H0: Rho=0 
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Number of Observations 
 
serHDL      sertriglyc        leptin       insulin        homair      waisthip 
 
Age            0.12024        -0.00990      -0.32733      -0.15265      -0.15701       0.22637 
 0.5051          0.9564        0.0674        0.4042        0.3908        0.2128 
 33              33            32            32            32            32 
 
Height        -0.11095         0.12429       0.15270       0.31044       0.33961       0.05079 
 0.5388          0.4907        0.4041        0.0838        0.0572        0.7825 
 33              33            32            32            32            32 
 
Weight        -0.16635        -0.01255       0.77995       0.31515       0.58533       0.37361 
 0.3548          0.9447        <.0001        0.0789        0.0004        0.0352 
 33              33            32            32            32            32 
 
bmi           -0.14959        -0.03308       0.81641       0.24279       0.54246       0.37273 
 0.4060          0.8550        <.0001        0.1806        0.0013        0.0356 
 33              33            32            32            32            32 
 
MAMC          -0.21502        -0.13303       0.75711       0.15836       0.46242       0.32481 
 0.2454          0.4756        <.0001        0.4033        0.0101        0.0799 
 31              31            30            30            30            30 
 
TricepSF      -0.24718        -0.16229       0.75984       0.05477       0.45353       0.51888 
 0.1801          0.3831        <.0001        0.7738        0.0118        0.0033 
 31              31            30            30            30            30 
 
Hip           -0.03595        -0.00439       0.72116       0.17457       0.47185       0.14120 
 0.8451          0.9810        <.0001        0.3476        0.0074        0.4408 
 32              32            31            31            31            32 
 
Waist         -0.25341         0.04784       0.74213       0.27219       0.49609       0.64313 
 0.1547          0.7915        <.0001        0.1318        0.0039        <.0001 
 33              33            32            32            32            32 
 
FFM           -0.15610        -0.03272       0.67253       0.30263       0.57875       0.23388 
 0.3857          0.8565        <.0001        0.0923        0.0005        0.1976 
 33              33            32            32            32            32 
 
percbodFAT    -0.19238         0.11287       0.77223       0.27909       0.57969       0.44275 
 0.2835          0.5317        <.0001        0.1219        0.0005        0.0112 
 33              33            32            32            32            32 
 
systolic      -0.14843        -0.19319       0.29269      -0.04163       0.08624      -0.26418 
 0.4510          0.3246        0.1385        0.8367        0.6689        0.1830 
 28              28            27            27            27            27 
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Pearson Correlation Coefficients 
 Prob > |r| under H0: Rho=0 
 Number of Observations 
 
serHDL      sertriglyc        leptin       insulin        homair      waisthip 
 
diastolic     -0.15145        -0.17169       0.23077      -0.18658      -0.03101       0.07979 
 0.4417          0.3823        0.2468        0.3514        0.8780        0.6924 
 28              28            27            27            27            27 
 
serglucose     0.02622        -0.03194       0.13328       0.03614       0.29365       0.11834 
 0.8848          0.8599        0.4671        0.8443        0.1028        0.5189 
 33              33            32            32            32            32 
 
stotchol       0.65316        -0.04765      -0.08609       0.08829       0.04024      -0.12812 
 <.0001          0.7923        0.6394        0.6309        0.8269        0.4847 
 33              33            32            32            32            32 
 
serHDL         1.00000        -0.43385      -0.13593      -0.16167      -0.15988      -0.43767 
 0.0117        0.4582        0.3767        0.3821        0.0122 
 33              33            32            32            32            32 
 
sertriglyc    -0.43385         1.00000      -0.03893       0.49626       0.27484       0.14440 
 0.0117                        0.8325        0.0039        0.1279        0.4304 
 33              33            32            32            32            32 
 
leptin        -0.13593        -0.03893       1.00000       0.31670       0.56995       0.29037 
120
0.4582          0.8325                      0.0826        0.0008        0.1130 
 32              32            32            31            31            31 
 
insulin       -0.16167         0.49626       0.31670       1.00000       0.82634       0.14597 
 0.3767          0.0039        0.0826                      <.0001        0.4333 
 32              32            31            32            32            31 
 
homair        -0.15988         0.27484       0.56995       0.82634       1.00000       0.16430 
 0.3821          0.1279        0.0008        <.0001                      0.3771 
 32              32            31            32            32            31 
 
waisthip      -0.43767         0.14440       0.29037       0.14597       0.16430       1.00000 
 0.0122          0.4304        0.1130        0.4333        0.3771 
 32              32            31            31            31            32 
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The CORR Procedure 
 
20  Variables:    Age        Height     Weight     bmi        MAMC       TricepSF   Hip        Waist 
 FFM        percbodFAT systolic   diastolic  serglucose stotchol   serHDL 
 sertriglyc leptin     insulin    homair     waisthip 
 
Simple Statistics 
 
Variable             N          Mean       Std Dev           Sum       Minimum       Maximum 
 
Age                 48      34.06250       5.92293          1635      22.00000      45.00000 
 Height              48      64.83333       1.63516          3112      61.50000      67.50000 
 Weight              48     193.04167      38.74121          9266     107.50000     300.50000 
 bmi                 48      32.37613       6.55918          1554      18.20413      52.50226 
 MAMC                47      33.10426       4.42802          1556      24.50000      46.00000 
 TricepSF            48      32.25729       7.83474          1548      13.70000      48.00000 
 Hip                 48     117.12083      13.14876          5622      92.00000     150.00000 
 Waist               48     106.27708      13.93907          5101      77.50000     145.00000 
 FFM                 47     109.41489      12.79619          5143      83.50000     138.50000 
 percbodFAT          47      42.04894       6.68778          1976      22.50000      54.70000 
 systolic            44     124.22727      12.01523          5466      97.00000     145.00000 
 diastolic           44      80.75000       9.42319          3553      58.00000     100.00000 
 serglucose          48     112.50000      33.14443          5400      63.00000     262.00000 
 stotchol            48     196.75000      44.45246          9444      70.00000     274.00000 
 serHDL              48      47.95833      16.16023          2302      17.20000      87.90000 
 sertriglyc          48     145.64583      91.79568          6991      12.00000     476.00000 
 leptin              48      28.04396      12.31622          1346       4.20000      60.32000 
 insulin             47      41.62128      34.06625          1956       5.47000     171.18000 
 homair              47       5.03205       0.79468     236.50639       3.13964       6.84138 
 waisthip            48       0.90752       0.06173      43.56108       0.75278       1.08527 
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The CORR Procedure 
 
Pearson Correlation Coefficients 
 Prob > |r| under H0: Rho=0 
 Number of Observations 
 
Age       Height       Weight          bmi         MAMC     TricepSF          Hip 
 
Age            1.00000      0.20651      0.20862      0.14871      0.02977     -0.00780      0.13276 
 0.1591       0.1547       0.3131       0.8426       0.9580       0.3684 
 48           48           48           48           47           48           48 
 
Height         0.20651      1.00000      0.11968     -0.12848     -0.16599     -0.05903      0.03421 
 0.1591                    0.4178       0.3842       0.2648       0.6902       0.8175 
 48           48           48           48           47           48           48 
 
Weight         0.20862      0.11968      1.00000      0.96856      0.77323      0.70978      0.91700 
 0.1547       0.4178                    <.0001       <.0001       <.0001       <.0001 
 48           48           48           48           47           48           48 
 
bmi            0.14871     -0.12848      0.96856      1.00000      0.80177      0.72275      0.90985 
 0.3131       0.3842       <.0001                    <.0001       <.0001       <.0001 
 48           48           48           48           47           48           48 
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MAMC           0.02977     -0.16599      0.77323      0.80177      1.00000      0.73208      0.64711 
 0.8426       0.2648       <.0001       <.0001                    <.0001       <.0001 
 47           47           47           47           47           47           47 
 
TricepSF      -0.00780     -0.05903      0.70978      0.72275      0.73208      1.00000      0.64330 
 0.9580       0.6902       <.0001       <.0001       <.0001                    <.0001 
 48           48           48           48           47           48           48 
 
Hip            0.13276      0.03421      0.91700      0.90985      0.64711      0.64330      1.00000 
 0.3684       0.8175       <.0001       <.0001       <.0001       <.0001 
 48           48           48           48           47           48           48 
 
Waist          0.20528      0.10681      0.82956      0.79933      0.65955      0.53359      0.84382 
 0.1616       0.4700       <.0001       <.0001       <.0001       <.0001       <.0001 
 48           48           48           48           47           48           48 
 
FFM            0.20410      0.08215      0.86204      0.83784      0.62627      0.58052      0.77715 
 0.1688       0.5830       <.0001       <.0001       <.0001       <.0001       <.0001 
 47           47           47           47           46           47           47 
 
percbodFAT     0.13321      0.16208      0.83730      0.79685      0.69509      0.63473      0.78406 
 0.3720       0.2764       <.0001       <.0001       <.0001       <.0001       <.0001 
 47           47           47           47           46           47           47 
 
systolic       0.06306      0.03463      0.42638      0.40922      0.42402      0.27246      0.40422 
 0.6842       0.8234       0.0039       0.0058       0.0041       0.0736       0.0065 
 44           44           44           44           44           44           44 
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The CORR Procedure 
 
Pearson Correlation Coefficients 
 Prob > |r| under H0: Rho=0 
 Number of Observations 
 
Age       Height       Weight          bmi         MAMC     TricepSF          Hip 
 
diastolic     -0.14368     -0.08552      0.31719      0.33302      0.39160      0.37555      0.24561 
 0.3521       0.5810       0.0359       0.0272       0.0086       0.0120       0.1081 
 44           44           44           44           44           44           44 
 
serglucose    -0.03593      0.01983      0.18441      0.18152      0.03836      0.27663      0.25802 
 0.8084       0.8936       0.2096       0.2169       0.7979       0.0570       0.0766 
 48           48           48           48           47           48           48 
 
stotchol       0.15457      0.22246     -0.04217     -0.10314     -0.18024     -0.06201     -0.02734 
 0.2942       0.1286       0.7760       0.4854       0.2254       0.6755       0.8536 
 48           48           48           48           47           48           48 
 
serHDL        -0.09236      0.13935     -0.23254     -0.27387     -0.07873     -0.07151     -0.21541 
 0.5324       0.3449       0.1117       0.0596       0.5988       0.6291       0.1415 
 48           48           48           48           47           48           48 
 
sertriglyc     0.19199     -0.13386      0.03974      0.07110     -0.07912     -0.08994      0.15501 
 0.1911       0.3644       0.7886       0.6311       0.5970       0.5432       0.2928 
 48           48           48           48           47           48           48 
 
leptin         0.04870      0.04606      0.71515      0.70786      0.65763      0.47562      0.68908 
 0.7424       0.7559       <.0001       <.0001       <.0001       0.0006       <.0001 
 48           48           48           48           47           48           48 
 
insulin        0.14755      0.00718      0.43984      0.44646      0.45054      0.21789      0.40467 
 0.3223       0.9618       0.0020       0.0017       0.0017       0.1412       0.0048 
 47           47           47           47           46           47           47 
 
homair         0.12302      0.02795      0.50096      0.50031      0.45940      0.32135      0.50853 
 0.4100       0.8521       0.0003       0.0003       0.0013       0.0276       0.0003 
 47           47           47           47           46           47           47 
 
waisthip       0.13475      0.12691      0.08631      0.04615      0.16064     -0.02143     -0.01599 
 0.3612       0.3900       0.5597       0.7554       0.2807       0.8850       0.9141 
 48           48           48           48           47           48           48 
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The CORR Procedure 
 
Pearson Correlation Coefficients 
 Prob > |r| under H0: Rho=0 
 Number of Observations 
 
percbod 
 Waist         FFM         FAT    systolic    diastolic    serglucose    stotchol 
 
Age            0.20528     0.20410     0.13321     0.06306     -0.14368      -0.03593     0.15457 
 0.1616      0.1688      0.3720      0.6842       0.3521        0.8084      0.2942 
 48          47          47          44           44            48          48 
 
Height         0.10681     0.08215     0.16208     0.03463     -0.08552       0.01983     0.22246 
 0.4700      0.5830      0.2764      0.8234       0.5810        0.8936      0.1286 
 48          47          47          44           44            48          48 
 
Weight         0.82956     0.86204     0.83730     0.42638      0.31719       0.18441    -0.04217 
 <.0001      <.0001      <.0001      0.0039       0.0359        0.2096      0.7760 
 48          47          47          44           44            48          48 
 
bmi            0.79933     0.83784     0.79685     0.40922      0.33302       0.18152    -0.10314 
 <.0001      <.0001      <.0001      0.0058       0.0272        0.2169      0.4854 
 48          47          47          44           44            48          48 
 
MAMC           0.65955     0.62627     0.69509     0.42402      0.39160       0.03836    -0.18024 
 <.0001      <.0001      <.0001      0.0041       0.0086        0.7979      0.2254 
 47          46          46          44           44            47          47 
 
TricepSF       0.53359     0.58052     0.63473     0.27246      0.37555       0.27663    -0.06201 
 <.0001      <.0001      <.0001      0.0736       0.0120        0.0570      0.6755 
 48          47          47          44           44            48          48 
 
Hip            0.84382     0.77715     0.78406     0.40422      0.24561       0.25802    -0.02734 
 <.0001      <.0001      <.0001      0.0065       0.1081        0.0766      0.8536 
 48          47          47          44           44            48          48 
 
Waist          1.00000     0.61578     0.80004     0.33381      0.12723       0.22131    -0.06254 
 <.0001      <.0001      0.0268       0.4105        0.1306      0.6728 
 48          47          47          44           44            48          48 
 
FFM            0.61578     1.00000     0.48219     0.43050      0.29431       0.20524     0.00841 
 <.0001                  0.0006      0.0040       0.0554        0.1664      0.9552 
 47          47          47          43           43            47          47 
 
percbodFAT     0.80004     0.48219     1.00000     0.38035      0.31096       0.13279    -0.10614 
 <.0001      0.0006                  0.0119       0.0424        0.3736      0.4777 
 47          47          47          43           43            47          47 
 
systolic       0.33381     0.43050     0.38035     1.00000      0.71017      -0.01223    -0.02238 
 0.0268      0.0040      0.0119                   <.0001        0.9372      0.8853 
 44          43          43          44           44            44          44 
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Pearson Correlation Coefficients 
 Prob > |r| under H0: Rho=0 
 Number of Observations 
 
percbod 
 Waist         FFM         FAT    systolic    diastolic    serglucose    stotchol 
 
diastolic      0.12723     0.29431     0.31096     0.71017      1.00000      -0.14737    -0.00817 
 0.4105      0.0554      0.0424      <.0001                     0.3398      0.9580 
 44          43          43          44           44            44          44 
 
serglucose     0.22131     0.20524     0.13279    -0.01223     -0.14737       1.00000     0.08890 
 0.1306      0.1664      0.3736      0.9372       0.3398                    0.5479 
 48          47          47          44           44            48          48 
 
stotchol      -0.06254     0.00841    -0.10614    -0.02238     -0.00817       0.08890     1.00000 
 0.6728      0.9552      0.4777      0.8853       0.9580        0.5479 
 48          47          47          44           44            48          48 
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serHDL        -0.06582    -0.32150    -0.09936    -0.00489      0.05165      -0.03529     0.40375 
 0.6567      0.0276      0.5064      0.9749       0.7392        0.8118      0.0044 
 48          47          47          44           44            48          48 
 
sertriglyc     0.10458     0.17555    -0.06337    -0.09579     -0.21959       0.24902     0.35936 
 0.4793      0.2379      0.6722      0.5362       0.1521        0.0879      0.0121 
 48          47          47          44           44            48          48 
 
leptin         0.56432     0.54761     0.66557     0.32266      0.27794       0.08427     0.12212 
 <.0001      <.0001      <.0001      0.0327       0.0677        0.5691      0.4083 
 48          47          47          44           44            48          48 
 
insulin        0.36265     0.37431     0.35968     0.09966     -0.06512       0.11948     0.01932 
 0.0122      0.0104      0.0141      0.5249       0.6782        0.4238      0.8974 
 47          46          46          43           43            47          47 
 
homair         0.40403     0.49196     0.39892     0.14893     -0.09357       0.37557     0.07723 
 0.0049      0.0005      0.0060      0.3405       0.5507        0.0093      0.6059 
 47          46          46          43           43            47          47 
 
waisthip       0.51952    -0.09809     0.25549    -0.03453     -0.15958      -0.00683    -0.05292 
 0.0002      0.5118      0.0830      0.8239       0.3008        0.9632      0.7209 
 48          47          47          44           44            48          48 
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Pearson Correlation Coefficients 
 Prob > |r| under H0: Rho=0 
 Number of Observations 
 
serHDL      sertriglyc        leptin       insulin        homair      waisthip 
 
Age           -0.09236         0.19199       0.04870       0.14755       0.12302       0.13475 
 0.5324          0.1911        0.7424        0.3223        0.4100        0.3612 
 48              48            48            47            47            48 
 
Height         0.13935        -0.13386       0.04606       0.00718       0.02795       0.12691 
 0.3449          0.3644        0.7559        0.9618        0.8521        0.3900 
 48              48            48            47            47            48 
 
Weight        -0.23254         0.03974       0.71515       0.43984       0.50096       0.08631 
 0.1117          0.7886        <.0001        0.0020        0.0003        0.5597 
 48              48            48            47            47            48 
 
bmi           -0.27387         0.07110       0.70786       0.44646       0.50031       0.04615 
 0.0596          0.6311        <.0001        0.0017        0.0003        0.7554 
 48              48            48            47            47            48 
 
MAMC          -0.07873        -0.07912       0.65763       0.45054       0.45940       0.16064 
 0.5988          0.5970        <.0001        0.0017        0.0013        0.2807 
 47              47            47            46            46            47 
 
TricepSF      -0.07151        -0.08994       0.47562       0.21789       0.32135      -0.02143 
 0.6291          0.5432        0.0006        0.1412        0.0276        0.8850 
 48              48            48            47            47            48 
 
Hip           -0.21541         0.15501       0.68908       0.40467       0.50853      -0.01599 
 0.1415          0.2928        <.0001        0.0048        0.0003        0.9141 
 48              48            48            47            47            48 
 
Waist         -0.06582         0.10458       0.56432       0.36265       0.40403       0.51952 
 0.6567          0.4793        <.0001        0.0122        0.0049        0.0002 
 48              48            48            47            47            48 
 
FFM           -0.32150         0.17555       0.54761       0.37431       0.49196      -0.09809 
 0.0276          0.2379        <.0001        0.0104        0.0005        0.5118 
 47              47            47            46            46            47 
 
percbodFAT    -0.09936        -0.06337       0.66557       0.35968       0.39892       0.25549 
 0.5064          0.6722        <.0001        0.0141        0.0060        0.0830 
 47              47            47            46            46            47 
 
systolic      -0.00489        -0.09579       0.32266       0.09966       0.14893      -0.03453 
 0.9749          0.5362        0.0327        0.5249        0.3405        0.8239 
 44              44            44            43            43            44 
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Pearson Correlation Coefficients 
 Prob > |r| under H0: Rho=0 
 Number of Observations 
 
serHDL      sertriglyc        leptin       insulin        homair      waisthip 
 
diastolic      0.05165        -0.21959       0.27794      -0.06512      -0.09357      -0.15958 
 0.7392          0.1521        0.0677        0.6782        0.5507        0.3008 
 44              44            44            43            43            44 
 
serglucose    -0.03529         0.24902       0.08427       0.11948       0.37557      -0.00683 
 0.8118          0.0879        0.5691        0.4238        0.0093        0.9632 
 48              48            48            47            47            48 
 
stotchol       0.40375         0.35936       0.12212       0.01932       0.07723      -0.05292 
 0.0044          0.0121        0.4083        0.8974        0.6059        0.7209 
 48              48            48            47            47            48 
 
serHDL         1.00000        -0.08327       0.01854       0.04613       0.00696       0.21101 
 0.5736        0.9005        0.7582        0.9630        0.1500 
 48              48            48            47            47            48 
 
sertriglyc    -0.08327         1.00000       0.06137       0.26609       0.29016      -0.02871 
 0.5736                        0.6786        0.0706        0.0479        0.8464 
 48              48            48            47            47            48 
 
leptin         0.01854         0.06137       1.00000       0.47323       0.56351      -0.04455 
 0.9005          0.6786                      0.0008        <.0001        0.7637 
 48              48            48            47            47            48 
 
insulin        0.04613         0.26609       0.47323       1.00000       0.87311       0.01296 
 0.7582          0.0706        0.0008                      <.0001        0.9311 
 47              47            47            47            47            47 
 
homair         0.00696         0.29016       0.56351       0.87311       1.00000      -0.07175 
 0.9630          0.0479        <.0001        <.0001                      0.6318 
 47              47            47            47            47            47 
 
waisthip       0.21101        -0.02871      -0.04455       0.01296      -0.07175       1.00000 
 0.1500          0.8464        0.7637        0.9311        0.6318 
 48              48            48            47            47            48 
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7 Variables:    Waist      systolic   Age        serHDL     stotchol   sertriglyc homair 
 
Simple Statistics 
 
Variable             N          Mean       Std Dev           Sum       Minimum       Maximum 
 
Waist               81     107.28765      17.39697          8690      69.50000     150.00000 
 systolic            72     125.91667      12.82466          9066      97.00000     160.00000 
 Age                 81      34.23457       5.79714          2773      22.00000      45.00000 
 serHDL              81      49.98395      16.41779          4049      17.20000      87.90000 
 stotchol            81     195.95062      40.83592         15872      70.00000     274.00000 
 sertriglyc          81     125.24691      82.75997         10145       1.00000     476.00000 
 homair              79       5.01620       0.92057     396.27968       2.63147       7.08852 
 
Pearson Correlation Coefficients 
 Prob > |r| under H0: Rho=0 
 Number of Observations 
 
Waist    systolic         Age      serHDL    stotchol    sertriglyc      homair 
 
Waist          1.00000     0.26887     0.12741    -0.14724    -0.06140       0.04981     0.45538 
 0.0224      0.2570      0.1896      0.5861        0.6588      <.0001 
 81          72          81          81          81            81          79 
 
systolic       0.26887     1.00000    -0.01263    -0.04765    -0.13391      -0.15742     0.12076 
125
0.0224                  0.9161      0.6910      0.2621        0.1866      0.3194 
 72          72          72          72          72            72          70 
 
Age            0.12741    -0.01263     1.00000    -0.00147     0.17678       0.11439    -0.01052 
 0.2570      0.9161                  0.9896      0.1144        0.3092      0.9267 
 81          72          81          81          81            81          79 
 
serHDL        -0.14724    -0.04765    -0.00147     1.00000     0.48046      -0.21833    -0.07365 
 0.1896      0.6910      0.9896                  <.0001        0.0502      0.5189 
 81          72          81          81          81            81          79 
 
stotchol      -0.06140    -0.13391     0.17678     0.48046     1.00000       0.25065     0.06008 
 0.5861      0.2621      0.1144      <.0001                    0.0240      0.5989 
 81          72          81          81          81            81          79 
 
sertriglyc     0.04981    -0.15742     0.11439    -0.21833     0.25065       1.00000     0.26082 
 0.6588      0.1866      0.3092      0.0502      0.0240                    0.0203 
 81          72          81          81          81            81          79 
 
homair         0.45538     0.12076    -0.01052    -0.07365     0.06008       0.26082     1.00000 
 <.0001      0.3194      0.9267      0.5189      0.5989        0.0203 
 79          70          79          79          79            79          79 
 
Smoking levels among ethnic groups
chi analysis for smoking      
 
The FREQ Procedure 
 
Table of ethnicity by smoke 
 
ethnicity     smoke 
 
Frequency‚ 
 Expected ‚ 
 Percent  ‚ 
 Row Pct  ‚ 
 Col Pct  ‚       1‚       2‚  Total 
 ?????????ˆ????????ˆ????????ˆ
1 ‚ 6 ‚ 27 ‚     33 
 ‚ 12.375 ‚ 20.625 ‚ 
 ‚ 7.50 ‚  33.75 ‚  41.25 
 ‚ 18.18 ‚  81.82 ‚ 
 ‚ 20.00 ‚  54.00 ‚ 
 ?????????ˆ????????ˆ????????ˆ
3 ‚ 24 ‚     23 ‚     47 
 ‚ 17.625 ‚ 29.375 ‚ 
 ‚ 30.00 ‚  28.75 ‚  58.75 
 ‚ 51.06 ‚  48.94 ‚ 
 ‚ 80.00 ‚  46.00 ‚ 
 ?????????ˆ????????ˆ????????ˆ
Total          30       50       80 
 37.50    62.50   100.00 
 
Frequency Missing = 1 
 
chi analysis for smoking      
 
The FREQ Procedure 
 
Statistics for Table of ethnicity by smoke 
 
Statistic                     DF       Value      Prob 
 ?????????????????????????????????????????????????????? 
Chi-Square                     1      8.9439    0.0028 
 Likelihood Ratio Chi-Square    1      9.4224    0.0021 
 Continuity Adj. Chi-Square     1      7.5960    0.0058 
 Mantel-Haenszel Chi-Square     1      8.8321    0.0030 
 Phi Coefficient                      -0.3344 
 Contingency Coefficient               0.3171 
 Cramer's V                           -0.3344 
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Fisher's Exact Test 
 ?????????????????????????????????? 
Cell (1,1) Frequency (F)         6 
 Left-sided Pr <= F          0.0025 
 Right-sided Pr >= F         0.9995 
 
Table Probability (P)       0.0020 
 Two-sided Pr <= P           0.0045 
 
Effective Sample Size = 80 
 Frequency Missing = 1 
 
chi analysis for smoking      
 
The FREQ Procedure 
 
Summary Statistics for ethnicity by smoke 
 
Cochran-Mantel-Haenszel Statistics (Based on Table Scores) 
 
Statistic    Alternative Hypothesis    DF       Value      Prob 
 ??????????????????????????????????????????????????????????????? 
1 Nonzero Correlation        1      8.8321    0.0030 
 2 Row Mean Scores Differ     1      8.8321    0.0030 
 3 General Association        1      8.8321    0.0030 
 
Estimates of the Common Relative Risk (Row1/Row2) 
 
Type of Study     Method                  Value     95% Confidence Limits 
 ????????????????????????????????????????????????????????????????????????? 
Case-Control      Mantel-Haenszel        0.2130       0.0743       0.6106 
 (Odds Ratio)    Logit                  0.2130       0.0743       0.6106 
 
Cohort            Mantel-Haenszel        0.3561       0.1639       0.7736 
 (Col1 Risk)     Logit                  0.3561       0.1639       0.7736 
 
Cohort            Mantel-Haenszel        1.6719       1.1979       2.3335 
 (Col2 Risk)     Logit                  1.6719       1.1979       2.3335 
 
Effective Sample Size = 80 
 Frequency Missing = 1 
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